| 11609818 | CV315338 | single nucleotide variant | NM_020376.4(PNPLA2):c.-31C>T | Neutral lipid storage myopathy [RCV000372944] | uncertain significance | 11 | 819688 | 819688 | Human | 1 | name |
| 11616484 | CV328265 | single nucleotide variant | NM_020376.4(PNPLA2):c.-19C>A | Neutral lipid storage myopathy [RCV000294803] | likely benign|uncertain significance | 11 | 819700 | 819700 | Human | 1 | name |
| 28871880 | CV868871 | single nucleotide variant | NM_020376.4(PNPLA2):c.-83G>A | Neutral lipid storage myopathy [RCV001114287] | uncertain significance | 11 | 819636 | 819636 | Human | 1 | name |
| 28872274 | CV868879 | single nucleotide variant | NM_020376.4(PNPLA2):c.*17A>G | Neutral lipid storage myopathy [RCV001114466] | uncertain significance | 11 | 824879 | 824879 | Human | 1 | name |
| 28872277 | CV868880 | single nucleotide variant | NM_020376.4(PNPLA2):c.*88G>T | Neutral lipid storage myopathy [RCV001114467] | uncertain significance | 11 | 824950 | 824950 | Human | 1 | name |
| 11600588 | CV315348 | single nucleotide variant | NM_020376.4(PNPLA2):c.*383C>T | Neutral lipid storage myopathy [RCV000274864]|not provided [RCV004693069] | uncertain significance | 11 | 825245 | 825245 | Human | 1 | name |
| 11606123 | CV315349 | single nucleotide variant | NM_020376.4(PNPLA2):c.*479C>T | Neutral lipid storage myopathy [RCV000327657] | likely benign|uncertain significance | 11 | 825341 | 825341 | Human | 1 | name |
| 11599877 | CV315352 | single nucleotide variant | NM_020376.4(PNPLA2):c.*596C>G | Neutral lipid storage myopathy [RCV000269030] | benign|likely benign | 11 | 825458 | 825458 | Human | 1 | name |
| 11655553 | CV315358 | single nucleotide variant | NM_020376.4(PNPLA2):c.*637C>T | Neutral lipid storage myopathy [RCV000326538] | uncertain significance | 11 | 825499 | 825499 | Human | 1 | name |
| 11605119 | CV322188 | single nucleotide variant | NM_020376.4(PNPLA2):c.-117G>A | Neutral lipid storage myopathy [RCV000316031]|not provided [RCV004693067] | uncertain significance | 11 | 819602 | 819602 | Human | 1 | name |
| 11609364 | CV322211 | single nucleotide variant | NM_020376.4(PNPLA2):c.*302G>A | Neutral lipid storage myopathy [RCV000366904] | uncertain significance | 11 | 825164 | 825164 | Human | 1 | name |
| 11645507 | CV328250 | single nucleotide variant | NM_020376.4(PNPLA2):c.-165A>G | Neutral lipid storage myopathy [RCV000265733] | uncertain significance | 11 | 818939 | 818939 | Human | 1 | name |
| 11619066 | CV328260 | single nucleotide variant | NM_020376.4(PNPLA2):c.-159A>G | Neutral lipid storage myopathy [RCV000320879] | uncertain significance | 11 | 818945 | 818945 | Human | 1 | name |
| 11612882 | CV328261 | single nucleotide variant | NM_020376.4(PNPLA2):c.-118C>T | Neutral lipid storage myopathy [RCV000263198]|not provided [RCV004693066] | uncertain significance | 11 | 819601 | 819601 | Human | 1 | name |
| 11626212 | CV328308 | single nucleotide variant | NM_020376.4(PNPLA2):c.*248A>G | Neutral lipid storage myopathy [RCV000408389]|not provided [RCV001636876] | benign | 11 | 825110 | 825110 | Human | 3 | name |
| 11618514 | CV329609 | single nucleotide variant | NM_020376.4(PNPLA2):c.*288C>T | Neutral lipid storage myopathy [RCV000314606]|not provided [RCV004705231] | likely benign|uncertain significance | 11 | 825150 | 825150 | Human | 1 | name |
| 11622920 | CV329610 | single nucleotide variant | NM_020376.4(PNPLA2):c.*567G>C | Neutral lipid storage myopathy [RCV000365859] | uncertain significance | 11 | 825429 | 825429 | Human | 1 | name |
| 28869083 | CV868869 | single nucleotide variant | NM_020376.4(PNPLA2):c.-167G>T | Neutral lipid storage myopathy [RCV001112927] | uncertain significance | 11 | 818937 | 818937 | Human | 1 | name |
| 28871879 | CV868870 | single nucleotide variant | NM_020376.4(PNPLA2):c.-120C>T | Neutral lipid storage myopathy [RCV001114286] | uncertain significance | 11 | 819599 | 819599 | Human | 1 | name |
| 28872281 | CV868881 | single nucleotide variant | NM_020376.4(PNPLA2):c.*134C>G | Neutral lipid storage myopathy [RCV001114468] | uncertain significance | 11 | 824996 | 824996 | Human | 1 | name |
| 28872284 | CV868882 | single nucleotide variant | NM_020376.4(PNPLA2):c.*160C>A | Neutral lipid storage myopathy [RCV001114469] | uncertain significance | 11 | 825022 | 825022 | Human | 1 | name |
| 28911373 | CV868883 | single nucleotide variant | NM_020376.4(PNPLA2):c.*232C>T | Neutral lipid storage myopathy [RCV001110442] | uncertain significance | 11 | 825094 | 825094 | Human | 1 | name |
| 28911374 | CV868884 | single nucleotide variant | NM_020376.4(PNPLA2):c.*384C>T | Neutral lipid storage myopathy [RCV001110443] | uncertain significance | 11 | 825246 | 825246 | Human | 1 | name |
| 28911375 | CV868885 | single nucleotide variant | NM_020376.4(PNPLA2):c.*385G>T | Neutral lipid storage myopathy [RCV001110444] | uncertain significance | 11 | 825247 | 825247 | Human | 1 | name |
| 28911792 | CV868886 | single nucleotide variant | NM_020376.4(PNPLA2):c.*568A>C | Neutral lipid storage myopathy [RCV001111186] | uncertain significance | 11 | 825430 | 825430 | Human | 1 | name |
| 28911793 | CV868887 | single nucleotide variant | NM_020376.4(PNPLA2):c.*595C>A | Neutral lipid storage myopathy [RCV001111187] | uncertain significance | 11 | 825457 | 825457 | Human | 1 | name |
| 28911794 | CV868888 | single nucleotide variant | NM_020376.4(PNPLA2):c.*603A>G | Neutral lipid storage myopathy [RCV001111188] | uncertain significance | 11 | 825465 | 825465 | Human | 1 | name |
| 127233475 | CV1053988 | single nucleotide variant | NM_020376.4(PNPLA2):c.758-1G>C | Neutral lipid storage myopathy [RCV001376180] | likely pathogenic | 11 | 823693 | 823693 | Human | 1 | name |
| 127276992 | CV1078959 | single nucleotide variant | NM_020376.4(PNPLA2):c.486+9T>G | Neutral lipid storage myopathy [RCV001407496] | likely benign | 11 | 822032 | 822032 | Human | 1 | name |
| 127278187 | CV1100683 | single nucleotide variant | NM_020376.4(PNPLA2):c.420+8C>G | Neutral lipid storage myopathy [RCV001444882] | likely benign | 11 | 821868 | 821868 | Human | 1 | name |
| 150408748 | CV1182195 | single nucleotide variant | NM_020376.4(PNPLA2):c.919+8C>G | Myopathy [RCV001553540] | uncertain significance | 11 | 823863 | 823863 | Human | 2 | name |
| 151730973 | CV1420744 | single nucleotide variant | NM_020376.4(PNPLA2):c.919+5G>C | Neutral lipid storage myopathy [RCV002041191] | uncertain significance | 11 | 823860 | 823860 | Human | 1 | name |
| 151722579 | CV1422034 | single nucleotide variant | NM_020376.4(PNPLA2):c.757+6C>T | Neutral lipid storage myopathy [RCV001909945] | uncertain significance | 11 | 823593 | 823593 | Human | 1 | name |
| 152149136 | CV1593099 | single nucleotide variant | NM_020376.4(PNPLA2):c.919+8C>T | Neutral lipid storage myopathy [RCV002101951] | likely benign | 11 | 823863 | 823863 | Human | 1 | name |
| 156386021 | CV1891803 | single nucleotide variant | NM_020376.4(PNPLA2):c.421-1G>A | Neutral lipid storage myopathy [RCV003067561] | likely pathogenic | 11 | 821957 | 821957 | Human | 1 | name |
| 11550205 | CV254342 | single nucleotide variant | NM_020376.4(PNPLA2):c.487-8C>T | Neutral lipid storage myopathy [RCV000401409]|not provided [RCV001200078]|not specified [RCV000251437] | likely benign|conflicting interpretations of pathogenicity|uncertain significance | 11 | 822389 | 822389 | Human | 1 | name |
| 11548415 | CV254349 | single nucleotide variant | NM_020376.4(PNPLA2):c.919+4C>T | Neutral lipid storage myopathy [RCV000274490]|not provided [RCV000858896]|not specified [RCV000249057] | benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance | 11 | 823859 | 823859 | Human | 1 | name |
| 405110253 | CV2876627 | single nucleotide variant | NM_020376.4(PNPLA2):c.920-5C>T | Neutral lipid storage myopathy [RCV003499168] | likely benign | 11 | 823993 | 823993 | Human | 1 | name |
| 405019404 | CV2947944 | single nucleotide variant | NM_020376.4(PNPLA2):c.421-9G>T | Neutral lipid storage myopathy [RCV003600587] | likely benign | 11 | 821949 | 821949 | Human | 1 | name |
| 405033553 | CV3080255 | single nucleotide variant | NM_020376.4(PNPLA2):c.188-4C>T | Neutral lipid storage myopathy [RCV003601981] | likely benign | 11 | 821624 | 821624 | Human | 1 | name |
| 405176909 | CV3146890 | single nucleotide variant | NM_020376.4(PNPLA2):c.757+7G>A | Neutral lipid storage myopathy [RCV003841985] | likely benign | 11 | 823594 | 823594 | Human | 1 | name |
| 11617633 | CV328270 | single nucleotide variant | NM_020376.4(PNPLA2):c.487-7G>C | Neutral lipid storage myopathy [RCV000306235]|PNPLA2-related disorder [RCV003920265] | likely benign|conflicting interpretations of pathogenicity|uncertain significance | 11 | 822390 | 822390 | Human | 2 | name , trait , alternate_id |
| 597964717 | CV3750968 | single nucleotide variant | NM_020376.4(PNPLA2):c.421-6C>T | Neutral lipid storage myopathy [RCV005082530] | likely benign | 11 | 821952 | 821952 | Human | 1 | name |
| 597901399 | CV3779097 | single nucleotide variant | NM_020376.4(PNPLA2):c.920-6C>T | Neutral lipid storage myopathy [RCV005127174] | likely benign | 11 | 823992 | 823992 | Human | 1 | name |
| 597942876 | CV3780033 | single nucleotide variant | NM_020376.4(PNPLA2):c.421-2A>T | Neutral lipid storage myopathy [RCV005119042] | likely pathogenic | 11 | 821956 | 821956 | Human | 1 | name |
| 597974486 | CV3801801 | single nucleotide variant | NM_020376.4(PNPLA2):c.920-9C>T | Neutral lipid storage myopathy [RCV005143790] | likely benign | 11 | 823989 | 823989 | Human | 1 | name |
| 597850787 | CV3803685 | single nucleotide variant | NM_020376.4(PNPLA2):c.187+9G>A | Neutral lipid storage myopathy [RCV005145402] | likely benign | 11 | 819914 | 819914 | Human | 1 | name |
| 13467723 | CV462015 | single nucleotide variant | NM_020376.4(PNPLA2):c.697-3C>T | Neutral lipid storage myopathy [RCV000544096] | uncertain significance | 11 | 823524 | 823524 | Human | 1 | name |
| 8570684 | CV48464 | single nucleotide variant | NM_020376.4(PNPLA2):c.757+2T>C | Neutral lipid storage myopathy [RCV000033092] | pathogenic | 11 | 823589 | 823589 | Human | 1 | name |
| 8570686 | CV48466 | single nucleotide variant | NM_020376.4(PNPLA2):c.757+1G>T | Neutral lipid storage myopathy [RCV000033094] | pathogenic | 11 | 823588 | 823588 | Human | 1 | name |
| 13532222 | CV511948 | single nucleotide variant | NM_020376.4(PNPLA2):c.187+1G>C | Inborn genetic diseases [RCV000624017]|Neutral lipid storage myopathy [RCV003497872] | pathogenic|likely pathogenic | 11 | 819906 | 819906 | Human | 2 | name |
| 13814652 | CV564916 | single nucleotide variant | NM_020376.4(PNPLA2):c.757+5G>A | Neutral lipid storage myopathy [RCV000705182] | uncertain significance | 11 | 823592 | 823592 | Human | 1 | name |
| 14711522 | CV652603 | single nucleotide variant | NM_020376.4(PNPLA2):c.420+6G>T | Neutral lipid storage myopathy [RCV000818029] | uncertain significance | 11 | 821866 | 821866 | Human | 1 | name |
| 15139431 | CV744691 | single nucleotide variant | NM_020376.4(PNPLA2):c.919+9C>A | Neutral lipid storage myopathy [RCV002540184] | likely benign | 11 | 823864 | 823864 | Human | 1 | name |
| 15118278 | CV775760 | single nucleotide variant | NM_020376.4(PNPLA2):c.920-7C>T | Neutral lipid storage myopathy [RCV001433255] | likely benign | 11 | 823991 | 823991 | Human | 1 | name |
| 15197177 | CV775886 | single nucleotide variant | NM_020376.4(PNPLA2):c.758-4C>T | not provided [RCV000934436] | likely benign | 11 | 823690 | 823690 | Human | | name |
| 15104042 | CV787723 | single nucleotide variant | NM_020376.4(PNPLA2):c.757+9A>C | Neutral lipid storage myopathy [RCV002066453] | likely benign | 11 | 823596 | 823596 | Human | 1 | name |
| 15145190 | CV787840 | single nucleotide variant | NM_020376.4(PNPLA2):c.421-5T>C | Neutral lipid storage myopathy [RCV000983618] | likely benign | 11 | 821953 | 821953 | Human | 1 | name |
| 26889883 | CV851463 | single nucleotide variant | NM_020376.4(PNPLA2):c.919+3G>A | Neutral lipid storage myopathy [RCV001045793] | uncertain significance | 11 | 823858 | 823858 | Human | 1 | name |
| 28911697 | CV872147 | single nucleotide variant | NM_020376.4(PNPLA2):c.487-7G>A | Neutral lipid storage myopathy [RCV001111018]|PNPLA2-related disorder [RCV003953483] | likely benign|conflicting interpretations of pathogenicity|uncertain significance | 11 | 822390 | 822390 | Human | 2 | name , trait , alternate_id |
| 126751111 | CV1030578 | single nucleotide variant | NM_020376.4(PNPLA2):c.1176-4G>T | Neutral lipid storage myopathy [RCV001352375] | likely benign|uncertain significance | 11 | 824519 | 824519 | Human | 1 | name |
| 151236003 | CV1319433 | single nucleotide variant | NM_020376.4(PNPLA2):c.919+42G>A | not provided [RCV001797378] | likely benign | 11 | 823897 | 823897 | Human | | name |
| 152175561 | CV1526904 | single nucleotide variant | NM_020376.4(PNPLA2):c.920-18C>A | Neutral lipid storage myopathy [RCV002163696] | likely benign | 11 | 823980 | 823980 | Human | 1 | name |
| 152050235 | CV1527739 | single nucleotide variant | NM_020376.4(PNPLA2):c.486+15C>T | Neutral lipid storage myopathy [RCV002089062] | likely benign | 11 | 822038 | 822038 | Human | 1 | name |
| 152138807 | CV1549586 | single nucleotide variant | NM_020376.4(PNPLA2):c.919+18G>C | Neutral lipid storage myopathy [RCV002156490]|not provided [RCV004706418] | likely benign | 11 | 823873 | 823873 | Human | 1 | name |
| 152168844 | CV1598218 | single nucleotide variant | NM_020376.4(PNPLA2):c.696+18G>C | Neutral lipid storage myopathy [RCV002142585] | likely benign | 11 | 822624 | 822624 | Human | 1 | name |
| 152101402 | CV1606873 | single nucleotide variant | NM_020376.4(PNPLA2):c.758-11C>T | Neutral lipid storage myopathy [RCV002195596] | likely benign | 11 | 823683 | 823683 | Human | 1 | name |
| 152049861 | CV1615209 | single nucleotide variant | NM_020376.4(PNPLA2):c.187+18C>A | Neutral lipid storage myopathy [RCV002089015] | likely benign | 11 | 819923 | 819923 | Human | 1 | name |
| 152053449 | CV1651566 | single nucleotide variant | NM_020376.4(PNPLA2):c.421-17C>T | Neutral lipid storage myopathy [RCV002145961] | likely benign | 11 | 821941 | 821941 | Human | 1 | name |
| 152147028 | CV1653569 | single nucleotide variant | NM_020376.4(PNPLA2):c.487-15T>C | Neutral lipid storage myopathy [RCV002138951] | likely benign | 11 | 822382 | 822382 | Human | 1 | name |
| 152144574 | CV1658165 | duplication | NM_020376.4(PNPLA2):c.757+15dup | Neutral lipid storage myopathy [RCV002219836] | likely benign | 11 | 823599 | 823600 | Human | 1 | name |
| 156386242 | CV1874975 | single nucleotide variant | NM_020376.4(PNPLA2):c.757+14G>A | Neutral lipid storage myopathy [RCV003050880] | likely benign | 11 | 823601 | 823601 | Human | 1 | name |
| 155996894 | CV1875951 | single nucleotide variant | NM_020376.4(PNPLA2):c.421-12C>T | Neutral lipid storage myopathy [RCV003076388] | likely benign | 11 | 821946 | 821946 | Human | 1 | name |
| 156386349 | CV1894075 | single nucleotide variant | NM_020376.4(PNPLA2):c.757+11C>A | Neutral lipid storage myopathy [RCV003093719] | likely benign | 11 | 823598 | 823598 | Human | 1 | name |
| 156136811 | CV1902053 | single nucleotide variant | NM_020376.4(PNPLA2):c.697-15C>A | Neutral lipid storage myopathy [RCV003082045] | likely benign | 11 | 823512 | 823512 | Human | 1 | name |
| 156413039 | CV1968922 | single nucleotide variant | NM_020376.4(PNPLA2):c.919+18G>T | Neutral lipid storage myopathy [RCV002608720] | likely benign | 11 | 823873 | 823873 | Human | 1 | name |
| 156342324 | CV1974181 | deletion | NM_020376.4(PNPLA2):c.757+15del | Neutral lipid storage myopathy [RCV002601346] | likely benign | 11 | 823600 | 823600 | Human | 1 | name |
| 156108305 | CV2002144 | single nucleotide variant | NM_020376.4(PNPLA2):c.696+18G>A | Neutral lipid storage myopathy [RCV002639839] | likely benign | 11 | 822624 | 822624 | Human | 1 | name |
| 156363758 | CV2003403 | single nucleotide variant | NM_020376.4(PNPLA2):c.758-10C>G | Neutral lipid storage myopathy [RCV002676419] | likely benign | 11 | 823684 | 823684 | Human | 1 | name |
| 156216334 | CV2047599 | single nucleotide variant | NM_020376.4(PNPLA2):c.696+14C>T | Neutral lipid storage myopathy [RCV002790452] | likely benign | 11 | 822620 | 822620 | Human | 1 | name |
| 155940804 | CV2054950 | single nucleotide variant | NM_020376.4(PNPLA2):c.758-10C>T | Neutral lipid storage myopathy [RCV002815683] | likely benign | 11 | 823684 | 823684 | Human | 1 | name |
| 156026212 | CV2108720 | single nucleotide variant | NM_020376.4(PNPLA2):c.758-14C>T | Neutral lipid storage myopathy [RCV002909853] | likely benign | 11 | 823680 | 823680 | Human | 1 | name |
| 156107964 | CV2149557 | single nucleotide variant | NM_020376.4(PNPLA2):c.1053-5C>G | Neutral lipid storage myopathy [RCV003021292] | likely benign | 11 | 824309 | 824309 | Human | 1 | name |
| 155967358 | CV2156145 | single nucleotide variant | NM_020376.4(PNPLA2):c.757+15G>A | Neutral lipid storage myopathy [RCV003015768] | likely benign | 11 | 823602 | 823602 | Human | 1 | name |
| 156014124 | CV2177301 | single nucleotide variant | NM_020376.4(PNPLA2):c.696+19A>G | Neutral lipid storage myopathy [RCV003035396] | likely benign | 11 | 822625 | 822625 | Human | 1 | name |
| 11550280 | CV254339 | single nucleotide variant | NM_020376.4(PNPLA2):c.187+15G>A | Neutral lipid storage myopathy [RCV000352052]|not provided [RCV001660341]|not specified [RCV000251538] | benign|likely benign | 11 | 819920 | 819920 | Human | 1 | name |
| 11548866 | CV254344 | single nucleotide variant | NM_020376.4(PNPLA2):c.696+15G>A | Neutral lipid storage myopathy [RCV001113011]|not provided [RCV002278213]|not specified [RCV000249659] | benign|likely benign | 11 | 822621 | 822621 | Human | 1 | name |
| 11551089 | CV254345 | single nucleotide variant | NM_020376.4(PNPLA2):c.696+16A>G | Neutral lipid storage myopathy [RCV001544061]|not provided [RCV001539697]|not specified [RCV000252594] | benign | 11 | 822622 | 822622 | Human | 1 | name |
| 11548483 | CV254347 | single nucleotide variant | NM_020376.4(PNPLA2):c.757+16C>T | Neutral lipid storage myopathy [RCV002058290]|not specified [RCV000249152] | benign|likely benign | 11 | 823603 | 823603 | Human | 1 | name |
| 405111164 | CV2869587 | single nucleotide variant | NM_020376.4(PNPLA2):c.757+13G>A | Neutral lipid storage myopathy [RCV003499195] | likely benign | 11 | 823600 | 823600 | Human | 1 | name |
| 405107810 | CV2921331 | single nucleotide variant | NM_020376.4(PNPLA2):c.696+14C>G | Neutral lipid storage myopathy [RCV003498556] | likely benign | 11 | 822620 | 822620 | Human | 1 | name |
| 405018657 | CV2947370 | single nucleotide variant | NM_020376.4(PNPLA2):c.919+18G>A | Neutral lipid storage myopathy [RCV003600533] | likely benign | 11 | 823873 | 823873 | Human | 1 | name |
| 405015814 | CV3049762 | single nucleotide variant | NM_020376.4(PNPLA2):c.758-20C>T | Neutral lipid storage myopathy [RCV003600300] | likely benign | 11 | 823674 | 823674 | Human | 1 | name |
| 405025984 | CV3069927 | deletion | NM_020376.4(PNPLA2):c.919+20del | Neutral lipid storage myopathy [RCV003601267] | likely benign | 11 | 823873 | 823873 | Human | 1 | name |
| 405102401 | CV3119158 | single nucleotide variant | NM_020376.4(PNPLA2):c.420+14G>A | Neutral lipid storage myopathy [RCV003811609] | likely benign | 11 | 821874 | 821874 | Human | 1 | name |
| 405109350 | CV3136772 | duplication | NM_020376.4(PNPLA2):c.919+15dup | Neutral lipid storage myopathy [RCV003835926] | benign | 11 | 823865 | 823866 | Human | 1 | name |
| 405247920 | CV3159114 | single nucleotide variant | NM_020376.4(PNPLA2):c.697-15C>T | Neutral lipid storage myopathy [RCV003869259] | likely benign | 11 | 823512 | 823512 | Human | 1 | name |
| 402519671 | CV3179397 | single nucleotide variant | NM_020376.4(PNPLA2):c.920-20G>A | Neutral lipid storage myopathy [RCV003879648] | likely benign | 11 | 823978 | 823978 | Human | 1 | name |
| 11619979 | CV328294 | single nucleotide variant | NM_020376.4(PNPLA2):c.920-13C>T | Neutral lipid storage myopathy [RCV000331362] | conflicting interpretations of pathogenicity|uncertain significance | 11 | 823985 | 823985 | Human | 1 | name |
| 597915590 | CV3767373 | single nucleotide variant | NM_020376.4(PNPLA2):c.187+12C>T | Neutral lipid storage myopathy [RCV005114364] | likely benign | 11 | 819917 | 819917 | Human | 1 | name |
| 597942829 | CV3786317 | single nucleotide variant | NM_020376.4(PNPLA2):c.1176-9G>A | Neutral lipid storage myopathy [RCV005134008] | likely benign | 11 | 824514 | 824514 | Human | 1 | name |
| 597858001 | CV3817009 | single nucleotide variant | NM_020376.4(PNPLA2):c.187+16G>A | Neutral lipid storage myopathy [RCV005146390] | likely benign | 11 | 819921 | 819921 | Human | 1 | name |
| 597941018 | CV3836797 | single nucleotide variant | NM_020376.4(PNPLA2):c.758-14C>G | Neutral lipid storage myopathy [RCV005187817] | likely benign | 11 | 823680 | 823680 | Human | 1 | name |
| 597965531 | CV3848303 | single nucleotide variant | NM_020376.4(PNPLA2):c.188-19C>G | Neutral lipid storage myopathy [RCV005194183] | likely benign | 11 | 821609 | 821609 | Human | 1 | name |
| 597930136 | CV3862306 | single nucleotide variant | NM_020376.4(PNPLA2):c.187+20G>A | Neutral lipid storage myopathy [RCV005206548] | likely benign | 11 | 819925 | 819925 | Human | 1 | name |
| 597929373 | CV3862863 | single nucleotide variant | NM_020376.4(PNPLA2):c.1176-3C>G | Neutral lipid storage myopathy [RCV005206397] | uncertain significance | 11 | 824520 | 824520 | Human | 1 | name |
| 14710948 | CV652135 | single nucleotide variant | NM_020376.4(PNPLA2):c.1175+3G>A | Neutral lipid storage myopathy [RCV000816172] | uncertain significance | 11 | 824439 | 824439 | Human | 1 | name |
| 28911696 | CV872146 | single nucleotide variant | NM_020376.4(PNPLA2):c.487-15T>G | Neutral lipid storage myopathy [RCV001111017] | conflicting interpretations of pathogenicity|uncertain significance | 11 | 822382 | 822382 | Human | 1 | name |
| 28872092 | CV872148 | single nucleotide variant | NM_020376.4(PNPLA2):c.757+11C>G | Neutral lipid storage myopathy [RCV001114385] | uncertain significance | 11 | 823598 | 823598 | Human | 1 | name |
| 150424738 | CV1184591 | single nucleotide variant | NM_020376.4(PNPLA2):c.1053-21C>T | not provided [RCV001557058] | likely benign | 11 | 824293 | 824293 | Human | | name |
| 150462037 | CV1253317 | single nucleotide variant | NM_020376.4(PNPLA2):c.696+216T>C | not provided [RCV001669646] | benign | 11 | 822822 | 822822 | Human | | name |
| 151233458 | CV1317088 | single nucleotide variant | NM_020376.4(PNPLA2):c.-145-48G>A | not provided [RCV001786909] | likely benign | 11 | 819526 | 819526 | Human | | name |
| 152089615 | CV1563126 | single nucleotide variant | NM_020376.4(PNPLA2):c.1175+18C>A | Neutral lipid storage myopathy [RCV002113893] | likely benign | 11 | 824454 | 824454 | Human | 1 | name |
| 152077228 | CV1604689 | single nucleotide variant | NM_020376.4(PNPLA2):c.1052+13G>A | Neutral lipid storage myopathy [RCV002092385] | likely benign | 11 | 824143 | 824143 | Human | 1 | name |
| 152140870 | CV1618566 | single nucleotide variant | NM_020376.4(PNPLA2):c.1053-20G>A | Neutral lipid storage myopathy [RCV002156752] | likely benign | 11 | 824294 | 824294 | Human | 1 | name |
| 152109231 | CV1623584 | duplication | NM_020376.4(PNPLA2):c.1052+19dup | Neutral lipid storage myopathy [RCV002215245] | likely benign | 11 | 824148 | 824149 | Human | 1 | name |
| 152055036 | CV1637230 | single nucleotide variant | NM_020376.4(PNPLA2):c.1052+15G>C | Neutral lipid storage myopathy [RCV002207976] | likely benign | 11 | 824145 | 824145 | Human | 1 | name |
| 152114736 | CV1659683 | single nucleotide variant | NM_020376.4(PNPLA2):c.1052+20G>A | Neutral lipid storage myopathy [RCV002080737] | likely benign | 11 | 824150 | 824150 | Human | 1 | name |
| 156408357 | CV1869981 | single nucleotide variant | NM_020376.4(PNPLA2):c.1053-16C>G | Neutral lipid storage myopathy [RCV003071236] | likely benign | 11 | 824298 | 824298 | Human | 1 | name |
| 156352042 | CV1883266 | single nucleotide variant | NM_020376.4(PNPLA2):c.1053-17G>A | Neutral lipid storage myopathy [RCV003091054] | likely benign | 11 | 824297 | 824297 | Human | 1 | name |
| 156412994 | CV1891501 | single nucleotide variant | NM_020376.4(PNPLA2):c.1053-13G>C | Neutral lipid storage myopathy [RCV003073113] | likely benign | 11 | 824301 | 824301 | Human | 1 | name |
| 156122870 | CV1952844 | single nucleotide variant | NM_020376.4(PNPLA2):c.1053-18C>T | Neutral lipid storage myopathy [RCV002571934] | likely benign | 11 | 824296 | 824296 | Human | 1 | name |
| 156228568 | CV2115487 | duplication | NM_020376.4(PNPLA2):c.1052+17dup | Neutral lipid storage myopathy [RCV002932736] | benign | 11 | 824141 | 824142 | Human | 1 | name |
| 405103910 | CV2905717 | single nucleotide variant | NM_020376.4(PNPLA2):c.1053-10C>A | Neutral lipid storage myopathy [RCV003497424] | likely benign | 11 | 824304 | 824304 | Human | 1 | name |
| 405033866 | CV3073879 | single nucleotide variant | NM_020376.4(PNPLA2):c.1053-14C>T | Neutral lipid storage myopathy [RCV003601898] | likely benign | 11 | 824300 | 824300 | Human | 1 | name |
| 11661360 | CV322187 | single nucleotide variant | NM_020376.4(PNPLA2):c.-145-11C>T | Neutral lipid storage myopathy [RCV000375537] | uncertain significance | 11 | 819563 | 819563 | Human | 1 | name |
| 597953857 | CV3795640 | single nucleotide variant | NM_020376.4(PNPLA2):c.1176-18C>T | Neutral lipid storage myopathy [RCV005136650] | likely benign | 11 | 824505 | 824505 | Human | 1 | name |
| 597858422 | CV3816649 | single nucleotide variant | NM_020376.4(PNPLA2):c.1053-12C>T | Neutral lipid storage myopathy [RCV005146222] | likely benign | 11 | 824302 | 824302 | Human | 1 | name |
| 597967157 | CV3823802 | single nucleotide variant | NM_020376.4(PNPLA2):c.1052+17G>A | Neutral lipid storage myopathy [RCV005165222] | likely benign | 11 | 824147 | 824147 | Human | 1 | name |
| 597967191 | CV3823885 | single nucleotide variant | NM_020376.4(PNPLA2):c.1175+10C>T | Neutral lipid storage myopathy [RCV005165305] | likely benign | 11 | 824446 | 824446 | Human | 1 | name |
| 597918609 | CV3842194 | single nucleotide variant | NM_020376.4(PNPLA2):c.1175+18C>G | Neutral lipid storage myopathy [RCV005183869] | likely benign | 11 | 824454 | 824454 | Human | 1 | name |
| 597919986 | CV3842578 | single nucleotide variant | NM_020376.4(PNPLA2):c.1053-16C>T | Neutral lipid storage myopathy [RCV005184063] | likely benign | 11 | 824298 | 824298 | Human | 1 | name |
| 13611061 | CV526554 | single nucleotide variant | NM_020376.4(PNPLA2):c.1052+10C>T | Neutral lipid storage myopathy [RCV000641670] | likely benign | 11 | 824140 | 824140 | Human | 1 | name |
| 14707066 | CV665287 | single nucleotide variant | NM_020376.4(PNPLA2):c.-145-88T>C | not provided [RCV000826718] | benign | 11 | 819486 | 819486 | Human | | name |
| 14721827 | CV665897 | single nucleotide variant | NM_020376.4(PNPLA2):c.1176-27C>G | not provided [RCV000831838] | benign | 11 | 824496 | 824496 | Human | | name |
| 14707069 | CV666312 | single nucleotide variant | NM_020376.4(PNPLA2):c.187+222T>G | not provided [RCV000826719] | benign | 11 | 820127 | 820127 | Human | | name |
| 28911746 | CV872149 | single nucleotide variant | NM_020376.4(PNPLA2):c.1052+12G>T | Neutral lipid storage myopathy [RCV001111095] | uncertain significance | 11 | 824142 | 824142 | Human | 1 | name |
| 150492820 | CV1238548 | single nucleotide variant | NM_020376.4(PNPLA2):c.-145-110T>G | not provided [RCV001655092] | benign | 11 | 819464 | 819464 | Human | | name |
| 11621935 | CV328307 | microsatellite | NM_020376.4(PNPLA2):c.*126TGCA[1] | Neutral lipid storage myopathy [RCV000354073]|not provided [RCV001707638] | benign | 11 | 824988 | 824991 | Human | | name |
| 597901410 | CV3835469 | microsatellite | NM_020376.4(PNPLA2):c.487-17TG[2] | Neutral lipid storage myopathy [RCV005181193] | likely benign | 11 | 822380 | 822381 | Human | | name |
| 150513804 | CV1210699 | microsatellite | NM_020376.4(PNPLA2):c.696+205TC[6] | not provided [RCV001598740] | benign | 11 | 822810 | 822811 | Human | | name |
| 126770696 | CV1010034 | duplication | NM_020376.4(PNPLA2):c.754_757+14dup | Neutral lipid storage myopathy [RCV001322728] | uncertain significance | 11 | 823580 | 823581 | Human | 1 | name |
| 151878632 | CV1350345 | deletion | NM_020376.4(PNPLA2):c.919+4_919+18del | Neutral lipid storage myopathy [RCV002036566] | uncertain significance | 11 | 823858 | 823872 | Human | 1 | name |
| 151830825 | CV1384501 | microsatellite | NM_020376.4(PNPLA2):c.697-10_697-8del | Neutral lipid storage myopathy [RCV001955664] | likely benign|uncertain significance | 11 | 823513 | 823515 | Human | | name |
| 152047815 | CV1519816 | single nucleotide variant | NM_020376.4(PNPLA2):c.21G>A (p.Thr7=) | Neutral lipid storage myopathy [RCV002145286] | likely benign | 11 | 819739 | 819739 | Human | 1 | name |
| 405244252 | CV3161156 | single nucleotide variant | NM_020376.4(PNPLA2):c.18G>A (p.Lys6=) | Neutral lipid storage myopathy [RCV003868065] | likely benign | 11 | 819736 | 819736 | Human | 1 | name |
| 127276349 | CV1100687 | deletion | NM_020376.4(PNPLA2):c.1176-6_1176-5del | Neutral lipid storage myopathy [RCV001432745] | likely benign | 11 | 824515 | 824516 | Human | 1 | name |
| 127300925 | CV1122132 | single nucleotide variant | NM_020376.4(PNPLA2):c.90C>G (p.Arg30=) | Neutral lipid storage myopathy [RCV001461229]|not provided [RCV003426114] | likely benign | 11 | 819808 | 819808 | Human | 1 | name |
| 127312518 | CV1122133 | single nucleotide variant | NM_020376.4(PNPLA2):c.96C>T (p.His32=) | Neutral lipid storage myopathy [RCV001464427] | likely benign | 11 | 819814 | 819814 | Human | 1 | name |
| 156449365 | CV1944632 | duplication | NM_020376.4(PNPLA2):c.757+20_757+33dup | Neutral lipid storage myopathy [RCV003121486] | likely benign | 11 | 823604 | 823605 | Human | 1 | name |
| 156447165 | CV1944863 | microsatellite | NM_020376.4(PNPLA2):c.487-18_487-15del | Neutral lipid storage myopathy [RCV003118692] | likely benign | 11 | 822375 | 822378 | Human | | name |
| 156392573 | CV2123556 | single nucleotide variant | NM_020376.4(PNPLA2):c.33G>C (p.Ser11=) | Neutral lipid storage myopathy [RCV002944061] | likely benign | 11 | 819751 | 819751 | Human | 1 | name |
| 405030229 | CV2968576 | deletion | NM_020376.4(PNPLA2):c.919+21_919+24del | Neutral lipid storage myopathy [RCV003601520] | likely benign | 11 | 823873 | 823876 | Human | 1 | name |
| 405090341 | CV3167854 | single nucleotide variant | NM_020376.4(PNPLA2):c.60C>T (p.Val20=) | Neutral lipid storage myopathy [RCV003852244] | likely benign | 11 | 819778 | 819778 | Human | 1 | name |
| 597907079 | CV3773139 | deletion | NM_020376.4(PNPLA2):c.919+18_919+25del | Neutral lipid storage myopathy [RCV005113204] | likely benign | 11 | 823873 | 823880 | Human | 1 | name |
| 597971840 | CV3798921 | duplication | NM_020376.4(PNPLA2):c.187+18_187+30dup | Neutral lipid storage myopathy [RCV005142333] | likely benign | 11 | 819916 | 819917 | Human | 1 | name |
| 13477358 | CV462002 | single nucleotide variant | NM_020376.4(PNPLA2):c.30C>T (p.Ile10=) | Neutral lipid storage myopathy [RCV001084806]|not provided [RCV000549557] | likely benign|conflicting interpretations of pathogenicity|uncertain significance | 11 | 819748 | 819748 | Human | 1 | name |
| 14720421 | CV640479 | single nucleotide variant | NM_020376.4(PNPLA2):c.72C>T (p.Gly24=) | Neutral lipid storage myopathy [RCV000813022] | likely benign|uncertain significance | 11 | 819790 | 819790 | Human | 1 | name |
| 15153679 | CV738333 | single nucleotide variant | NM_020376.4(PNPLA2):c.42C>T (p.Gly14=) | not provided [RCV000901807] | likely benign | 11 | 819760 | 819760 | Human | | name |
| 28911268 | CV868872 | single nucleotide variant | NM_020376.4(PNPLA2):c.36C>T (p.Phe12=) | Neutral lipid storage myopathy [RCV001110266] | conflicting interpretations of pathogenicity|uncertain significance | 11 | 819754 | 819754 | Human | 1 | name |
| 127335046 | CV1122134 | single nucleotide variant | NM_020376.4(PNPLA2):c.204G>A (p.Lys68=) | Neutral lipid storage myopathy [RCV001473988] | likely benign | 11 | 821644 | 821644 | Human | 1 | name |
| 151748699 | CV1383292 | single nucleotide variant | NM_020376.4(PNPLA2):c.10C>T (p.Arg4Cys) | Neutral lipid storage myopathy [RCV001947905]|not provided [RCV005225543] | uncertain significance | 11 | 819728 | 819728 | Human | 1 | name |
| 152128045 | CV1572183 | single nucleotide variant | NM_020376.4(PNPLA2):c.102C>T (p.Pro34=) | Neutral lipid storage myopathy [RCV002217679] | likely benign | 11 | 819820 | 819820 | Human | 1 | name |
| 152029761 | CV1653459 | single nucleotide variant | NM_020376.4(PNPLA2):c.117C>T (p.Asn39=) | Neutral lipid storage myopathy [RCV002085913] | likely benign | 11 | 819835 | 819835 | Human | 1 | name |
| 152089701 | CV1654716 | single nucleotide variant | NM_020376.4(PNPLA2):c.267C>T (p.Asn89=) | Neutral lipid storage myopathy [RCV002212554] | likely benign | 11 | 821707 | 821707 | Human | 1 | name |
| 156354731 | CV1880141 | single nucleotide variant | NM_020376.4(PNPLA2):c.241C>T (p.Leu81=) | Neutral lipid storage myopathy [RCV003065140] | likely benign | 11 | 821681 | 821681 | Human | 1 | name |
| 156296685 | CV1924155 | single nucleotide variant | NM_020376.4(PNPLA2):c.138C>T (p.Ala46=) | Neutral lipid storage myopathy [RCV002629047] | likely benign | 11 | 819856 | 819856 | Human | 1 | name |
| 156156540 | CV2033581 | single nucleotide variant | NM_020376.4(PNPLA2):c.123G>T (p.Thr41=) | Neutral lipid storage myopathy [RCV002741397] | likely benign | 11 | 819841 | 819841 | Human | 1 | name |
| 156103866 | CV2113502 | single nucleotide variant | NM_020376.4(PNPLA2):c.291C>T (p.Phe97=) | Neutral lipid storage myopathy [RCV002952839] | uncertain significance | 11 | 821731 | 821731 | Human | 1 | name |
| 11543016 | CV254340 | single nucleotide variant | NM_020376.4(PNPLA2):c.246C>A (p.Gly82=) | Neutral lipid storage myopathy [RCV000539182]|not specified [RCV000241898] | benign | 11 | 821686 | 821686 | Human | 1 | name |
| 405105452 | CV2858269 | single nucleotide variant | NM_020376.4(PNPLA2):c.171C>T (p.Val57=) | Neutral lipid storage myopathy [RCV003498124] | likely benign | 11 | 819889 | 819889 | Human | 1 | name |
| 405013113 | CV3022889 | single nucleotide variant | NM_020376.4(PNPLA2):c.250C>T (p.Leu84=) | Neutral lipid storage myopathy [RCV003599990] | likely benign | 11 | 821690 | 821690 | Human | 1 | name |
| 408386054 | CV3415526 | single nucleotide variant | NM_020376.4(PNPLA2):c.24G>A (p.Trp8Ter) | Neutral lipid storage myopathy [RCV004767627] | likely pathogenic | 11 | 819742 | 819742 | Human | 1 | name |
| 597927637 | CV3836979 | single nucleotide variant | NM_020376.4(PNPLA2):c.184C>T (p.Leu62=) | Neutral lipid storage myopathy [RCV005185330] | likely benign | 11 | 819902 | 819902 | Human | 1 | name |
| 13611056 | CV526790 | single nucleotide variant | NM_020376.4(PNPLA2):c.201C>G (p.Ala67=) | Neutral lipid storage myopathy [RCV000641668] | likely benign | 11 | 821641 | 821641 | Human | 1 | name |
| 13611249 | CV527073 | single nucleotide variant | NM_020376.4(PNPLA2):c.165G>C (p.Ala55=) | Neutral lipid storage myopathy [RCV001426509]|not provided [RCV003424218] | likely benign | 11 | 819883 | 819883 | Human | 1 | name |
| 15125240 | CV693116 | single nucleotide variant | NM_020376.4(PNPLA2):c.282C>T (p.Ile94=) | Neutral lipid storage myopathy [RCV000874917] | likely benign | 11 | 821722 | 821722 | Human | 1 | name |
| 15164097 | CV724771 | single nucleotide variant | NM_020376.4(PNPLA2):c.165G>T (p.Ala55=) | Neutral lipid storage myopathy [RCV000882121]|PNPLA2-related disorder [RCV003948318] | likely benign|conflicting interpretations of pathogenicity | 11 | 819883 | 819883 | Human | 2 | name , trait , alternate_id |
| 15102322 | CV768814 | single nucleotide variant | NM_020376.4(PNPLA2):c.177G>C (p.Gly59=) | Neutral lipid storage myopathy [RCV001428770]|PNPLA2-related disorder [RCV003983286] | likely benign | 11 | 819895 | 819895 | Human | 2 | name , trait , alternate_id |
| 15102143 | CV784230 | single nucleotide variant | NM_020376.4(PNPLA2):c.258C>T (p.Pro86=) | Neutral lipid storage myopathy [RCV001469365] | likely benign | 11 | 821698 | 821698 | Human | 1 | name |
| 26904868 | CV839115 | single nucleotide variant | NM_020376.4(PNPLA2):c.11G>A (p.Arg4His) | Neutral lipid storage myopathy [RCV001036756] | uncertain significance | 11 | 819729 | 819729 | Human | 1 | name |
| 126771653 | CV1030573 | single nucleotide variant | NM_020376.4(PNPLA2):c.74T>C (p.Val25Ala) | Inborn genetic diseases [RCV004960827]|Neutral lipid storage myopathy [RCV001345170] | uncertain significance | 11 | 819792 | 819792 | Human | 2 | name |
| 126916956 | CV1047577 | single nucleotide variant | NM_020376.4(PNPLA2):c.52C>T (p.Leu18Phe) | Neutral lipid storage myopathy [RCV001371798] | uncertain significance | 11 | 819770 | 819770 | Human | 1 | name |
| 126922453 | CV1047578 | single nucleotide variant | NM_020376.4(PNPLA2):c.80C>T (p.Ser27Phe) | Neutral lipid storage myopathy [RCV001364691] | uncertain significance | 11 | 819798 | 819798 | Human | 1 | name |
| 127232258 | CV1078960 | single nucleotide variant | NM_020376.4(PNPLA2):c.693C>G (p.Pro231=) | Neutral lipid storage myopathy [RCV001413372] | likely benign | 11 | 822603 | 822603 | Human | 1 | name |
| 127274652 | CV1078961 | single nucleotide variant | NM_020376.4(PNPLA2):c.813C>G (p.Gly271=) | Neutral lipid storage myopathy [RCV001406382]|not provided [RCV004707588] | likely benign | 11 | 823749 | 823749 | Human | 1 | name |
| 127267055 | CV1100684 | single nucleotide variant | NM_020376.4(PNPLA2):c.453C>T (p.Tyr151=) | Neutral lipid storage myopathy [RCV001440440] | likely benign | 11 | 821990 | 821990 | Human | 1 | name |
| 127265600 | CV1100685 | single nucleotide variant | NM_020376.4(PNPLA2):c.846C>T (p.Ala282=) | Neutral lipid storage myopathy [RCV001429138] | likely benign | 11 | 823782 | 823782 | Human | 1 | name |
| 127237351 | CV1100686 | single nucleotide variant | NM_020376.4(PNPLA2):c.939G>A (p.Val313=) | Neutral lipid storage myopathy [RCV001433517] | likely benign | 11 | 824017 | 824017 | Human | 1 | name |
| 127288839 | CV1143004 | single nucleotide variant | NM_020376.4(PNPLA2):c.381C>A (p.Val127=) | Neutral lipid storage myopathy [RCV001495433] | likely benign | 11 | 821821 | 821821 | Human | 1 | name |
| 127291302 | CV1143005 | single nucleotide variant | NM_020376.4(PNPLA2):c.408C>T (p.Asp136=) | Neutral lipid storage myopathy [RCV001496201] | likely benign | 11 | 821848 | 821848 | Human | 1 | name |
| 127314733 | CV1143006 | single nucleotide variant | NM_020376.4(PNPLA2):c.702G>T (p.Leu234=) | Neutral lipid storage myopathy [RCV001482324] | likely benign | 11 | 823532 | 823532 | Human | 1 | name |
| 151861520 | CV1374236 | single nucleotide variant | NM_020376.4(PNPLA2):c.687G>A (p.Pro229=) | Neutral lipid storage myopathy [RCV001938605] | conflicting interpretations of pathogenicity|uncertain significance | 11 | 822597 | 822597 | Human | 1 | name |
| 151877351 | CV1395489 | single nucleotide variant | NM_020376.4(PNPLA2):c.55G>C (p.Gly19Arg) | Neutral lipid storage myopathy [RCV002019700] | uncertain significance | 11 | 819773 | 819773 | Human | 1 | name |
| 151882869 | CV1443317 | single nucleotide variant | NM_020376.4(PNPLA2):c.77C>T (p.Ala26Val) | Inborn genetic diseases [RCV003289107]|Neutral lipid storage myopathy [RCV002037228] | uncertain significance | 11 | 819795 | 819795 | Human | 2 | name |
| 152055370 | CV1522598 | single nucleotide variant | NM_020376.4(PNPLA2):c.925C>T (p.Leu309=) | Neutral lipid storage myopathy [RCV002146159] | likely benign | 11 | 824003 | 824003 | Human | 1 | name |
| 152124511 | CV1527686 | single nucleotide variant | NM_020376.4(PNPLA2):c.783G>A (p.Leu261=) | Neutral lipid storage myopathy [RCV002082022] | likely benign | 11 | 823719 | 823719 | Human | 1 | name |
| 152036273 | CV1545966 | single nucleotide variant | NM_020376.4(PNPLA2):c.684G>T (p.Pro228=) | Neutral lipid storage myopathy [RCV002164993] | likely benign | 11 | 822594 | 822594 | Human | 1 | name |
| 152113899 | CV1559185 | single nucleotide variant | NM_020376.4(PNPLA2):c.828C>T (p.Asp276=) | Neutral lipid storage myopathy [RCV002174676] | likely benign | 11 | 823764 | 823764 | Human | 1 | name |
| 152171251 | CV1562229 | single nucleotide variant | NM_020376.4(PNPLA2):c.414C>T (p.Leu138=) | Neutral lipid storage myopathy [RCV002183436] | likely benign | 11 | 821854 | 821854 | Human | 1 | name |
| 152158164 | CV1564352 | single nucleotide variant | NM_020376.4(PNPLA2):c.891G>A (p.Leu297=) | Neutral lipid storage myopathy [RCV002140465]|PNPLA2-related disorder [RCV003958895] | likely benign | 11 | 823827 | 823827 | Human | 2 | name , trait , alternate_id |
| 152122901 | CV1570501 | single nucleotide variant | NM_020376.4(PNPLA2):c.516C>T (p.Asn172=) | Neutral lipid storage myopathy [RCV002217021]|PNPLA2-related disorder [RCV003893202] | likely benign | 11 | 822426 | 822426 | Human | 2 | name , trait , alternate_id |
| 152130825 | CV1585391 | single nucleotide variant | NM_020376.4(PNPLA2):c.789G>A (p.Ala263=) | Neutral lipid storage myopathy [RCV002155511] | likely benign | 11 | 823725 | 823725 | Human | 1 | name |
| 152081181 | CV1589370 | single nucleotide variant | NM_020376.4(PNPLA2):c.852G>A (p.Ala284=) | Neutral lipid storage myopathy [RCV002112772] | likely benign | 11 | 823788 | 823788 | Human | 1 | name |
| 152118461 | CV1602579 | single nucleotide variant | NM_020376.4(PNPLA2):c.936C>T (p.Cys312=) | Neutral lipid storage myopathy [RCV002117522] | likely benign | 11 | 824014 | 824014 | Human | 1 | name |
| 152138004 | CV1603837 | single nucleotide variant | NM_020376.4(PNPLA2):c.912C>T (p.Leu304=) | Neutral lipid storage myopathy [RCV002218985] | likely benign | 11 | 823848 | 823848 | Human | 1 | name |
| 152040598 | CV1644626 | single nucleotide variant | NM_020376.4(PNPLA2):c.609C>T (p.His203=) | Neutral lipid storage myopathy [RCV002165631] | likely benign | 11 | 822519 | 822519 | Human | 1 | name |
| 152114958 | CV1659722 | single nucleotide variant | NM_020376.4(PNPLA2):c.795C>G (p.Pro265=) | Neutral lipid storage myopathy [RCV002080766] | likely benign | 11 | 823731 | 823731 | Human | 1 | name |
| 156016924 | CV1885314 | single nucleotide variant | NM_020376.4(PNPLA2):c.88C>T (p.Arg30Cys) | Inborn genetic diseases [RCV003161700]|Neutral lipid storage myopathy [RCV003077414] | uncertain significance | 11 | 819806 | 819806 | Human | 2 | name |
| 156225535 | CV1981570 | single nucleotide variant | NM_020376.4(PNPLA2):c.868C>T (p.Leu290=) | Neutral lipid storage myopathy [RCV002626603] | likely benign | 11 | 823804 | 823804 | Human | 1 | name |
| 156384994 | CV2001768 | single nucleotide variant | NM_020376.4(PNPLA2):c.43T>A (p.Cys15Ser) | Neutral lipid storage myopathy [RCV002653928] | uncertain significance | 11 | 819761 | 819761 | Human | 1 | name |
| 156009629 | CV2011379 | single nucleotide variant | NM_020376.4(PNPLA2):c.843C>T (p.Ser281=) | Neutral lipid storage myopathy [RCV002690444] | likely benign | 11 | 823779 | 823779 | Human | 1 | name |
| 156361476 | CV2016693 | single nucleotide variant | NM_020376.4(PNPLA2):c.483G>C (p.Gly161=) | Neutral lipid storage myopathy [RCV002720893] | likely benign | 11 | 822020 | 822020 | Human | 1 | name |
| 156087083 | CV2034137 | single nucleotide variant | NM_020376.4(PNPLA2):c.426T>C (p.Asn142=) | Neutral lipid storage myopathy [RCV002760813] | likely benign | 11 | 821963 | 821963 | Human | 1 | name |
| 156142969 | CV2037145 | single nucleotide variant | NM_020376.4(PNPLA2):c.963C>T (p.Thr321=) | Neutral lipid storage myopathy [RCV002786590] | likely benign | 11 | 824041 | 824041 | Human | 1 | name |
| 155935974 | CV2045775 | single nucleotide variant | NM_020376.4(PNPLA2):c.543C>T (p.Thr181=) | Neutral lipid storage myopathy [RCV002751459]|PNPLA2-related disorder [RCV004756421] | likely benign | 11 | 822453 | 822453 | Human | 2 | name , trait , alternate_id |
| 156022983 | CV2105876 | single nucleotide variant | NM_020376.4(PNPLA2):c.795C>T (p.Pro265=) | Neutral lipid storage myopathy [RCV002923157] | likely benign | 11 | 823731 | 823731 | Human | 1 | name |
| 156037299 | CV2218567 | single nucleotide variant | NM_020376.4(PNPLA2):c.70G>T (p.Gly24Cys) | Inborn genetic diseases [RCV002692013] | uncertain significance | 11 | 819788 | 819788 | Human | 1 | name |
| 11546472 | CV254341 | single nucleotide variant | NM_020376.4(PNPLA2):c.369C>T (p.Asp123=) | Neutral lipid storage myopathy [RCV000293478]|not provided [RCV003422178]|not specified [RCV000246504] | likely benign|conflicting interpretations of pathogenicity|uncertain significance | 11 | 821809 | 821809 | Human | 1 | name |
| 11545117 | CV254343 | single nucleotide variant | NM_020376.4(PNPLA2):c.678C>T (p.Leu226=) | Neutral lipid storage myopathy [RCV000407009]|not provided [RCV001610716]|not specified [RCV000244708] | benign|likely benign|conflicting interpretations of pathogenicity | 11 | 822588 | 822588 | Human | 1 | name |
| 11544653 | CV254348 | single nucleotide variant | NM_020376.4(PNPLA2):c.873C>G (p.Pro291=) | Neutral lipid storage myopathy [RCV000261463]|not provided [RCV001711827]|not specified [RCV000244079] | benign | 11 | 823809 | 823809 | Human | 1 | name |
| 401907812 | CV2806411 | single nucleotide variant | NM_020376.4(PNPLA2):c.834A>C (p.Ala278=) | not provided [RCV003422924] | likely benign | 11 | 823770 | 823770 | Human | | name |
| 405110712 | CV2880112 | single nucleotide variant | NM_020376.4(PNPLA2):c.753G>A (p.Arg251=) | Neutral lipid storage myopathy [RCV003499164] | likely benign | 11 | 823583 | 823583 | Human | 1 | name |
| 405107358 | CV2909388 | single nucleotide variant | NM_020376.4(PNPLA2):c.738G>A (p.Leu246=) | Neutral lipid storage myopathy [RCV003498396] | likely benign | 11 | 823568 | 823568 | Human | 1 | name |
| 405107283 | CV2917243 | single nucleotide variant | NM_020376.4(PNPLA2):c.63C>G (p.Tyr21Ter) | Neutral lipid storage myopathy [RCV003498521] | pathogenic | 11 | 819781 | 819781 | Human | 1 | name |
| 405019618 | CV2939170 | single nucleotide variant | NM_020376.4(PNPLA2):c.675C>T (p.Ala225=) | Neutral lipid storage myopathy [RCV003600642] | likely benign | 11 | 822585 | 822585 | Human | 1 | name |
| 405028256 | CV2970929 | single nucleotide variant | NM_020376.4(PNPLA2):c.921C>G (p.Ala307=) | Neutral lipid storage myopathy [RCV003601433] | likely benign | 11 | 823999 | 823999 | Human | 1 | name |
| 405029246 | CV2976093 | single nucleotide variant | NM_020376.4(PNPLA2):c.792G>A (p.Leu264=) | Neutral lipid storage myopathy [RCV003601562] | likely benign | 11 | 823728 | 823728 | Human | 1 | name |
| 405036289 | CV2994946 | single nucleotide variant | NM_020376.4(PNPLA2):c.771G>A (p.Arg257=) | Neutral lipid storage myopathy [RCV003602112] | likely benign | 11 | 823707 | 823707 | Human | 1 | name |
| 405035907 | CV2996084 | single nucleotide variant | NM_020376.4(PNPLA2):c.927G>A (p.Leu309=) | Neutral lipid storage myopathy [RCV003602196] | likely benign | 11 | 824005 | 824005 | Human | 1 | name |
| 405038228 | CV3005542 | single nucleotide variant | NM_020376.4(PNPLA2):c.763C>T (p.Leu255=) | Neutral lipid storage myopathy [RCV003602383] | likely benign | 11 | 823699 | 823699 | Human | 1 | name |
| 405038015 | CV3007917 | single nucleotide variant | NM_020376.4(PNPLA2):c.393C>T (p.His131=) | Neutral lipid storage myopathy [RCV003602312] | likely benign | 11 | 821833 | 821833 | Human | 1 | name |
| 405015235 | CV3039417 | single nucleotide variant | NM_020376.4(PNPLA2):c.45C>A (p.Cys15Ter) | Neutral lipid storage myopathy [RCV003600240] | pathogenic | 11 | 819763 | 819763 | Human | 1 | name |
| 405016263 | CV3047042 | single nucleotide variant | NM_020376.4(PNPLA2):c.951C>T (p.Asp317=) | Neutral lipid storage myopathy [RCV003600345] | likely benign | 11 | 824029 | 824029 | Human | 1 | name |
| 405035038 | CV3070750 | single nucleotide variant | NM_020376.4(PNPLA2):c.441C>T (p.Phe147=) | Neutral lipid storage myopathy [RCV003601863] | likely benign | 11 | 821978 | 821978 | Human | 1 | name |
| 11607564 | CV315342 | single nucleotide variant | NM_020376.4(PNPLA2):c.591C>T (p.Asp197=) | Neutral lipid storage myopathy [RCV000344798]|PNPLA2-related disorder [RCV003910129] | likely benign|conflicting interpretations of pathogenicity|uncertain significance | 11 | 822501 | 822501 | Human | 2 | name , trait , alternate_id |
| 405254360 | CV3175052 | single nucleotide variant | NM_020376.4(PNPLA2):c.906C>T (p.Ala302=) | Neutral lipid storage myopathy [RCV003871504] | likely benign | 11 | 823842 | 823842 | Human | 1 | name |
| 405250654 | CV3180803 | single nucleotide variant | NM_020376.4(PNPLA2):c.76G>A (p.Ala26Thr) | Neutral lipid storage myopathy [RCV003870081] | uncertain significance | 11 | 819794 | 819794 | Human | 1 | name |
| 11607641 | CV322189 | single nucleotide variant | NM_020376.4(PNPLA2):c.399C>T (p.Asn133=) | Neutral lipid storage myopathy [RCV000346165] | likely benign|conflicting interpretations of pathogenicity|uncertain significance | 11 | 821839 | 821839 | Human | 1 | name |
| 11606550 | CV322201 | single nucleotide variant | NM_020376.4(PNPLA2):c.903C>T (p.Pro301=) | Neutral lipid storage myopathy [RCV000332934]|not provided [RCV003422255] | likely benign|conflicting interpretations of pathogenicity|uncertain significance | 11 | 823839 | 823839 | Human | 1 | name |
| 11622374 | CV328271 | single nucleotide variant | NM_020376.4(PNPLA2):c.747G>A (p.Leu249=) | Neutral lipid storage myopathy [RCV000359633] | likely benign|conflicting interpretations of pathogenicity|uncertain significance | 11 | 823577 | 823577 | Human | 1 | name |
| 11612844 | CV328278 | single nucleotide variant | NM_020376.4(PNPLA2):c.781T>C (p.Leu261=) | Neutral lipid storage myopathy [RCV000262589]|PNPLA2-related disorder [RCV003977890] | likely benign|conflicting interpretations of pathogenicity|uncertain significance | 11 | 823717 | 823717 | Human | 2 | name , trait , alternate_id |
| 11660917 | CV328281 | single nucleotide variant | NM_020376.4(PNPLA2):c.912C>A (p.Leu304=) | Neutral lipid storage myopathy [RCV000371374] | likely benign|conflicting interpretations of pathogenicity|uncertain significance | 11 | 823848 | 823848 | Human | 1 | name |
| 407429025 | CV3413412 | single nucleotide variant | NM_020376.4(PNPLA2):c.91G>T (p.Glu31Ter) | Neutral lipid storage myopathy [RCV004594819] | likely pathogenic | 11 | 819809 | 819809 | Human | 1 | name |
| 597963850 | CV3754216 | single nucleotide variant | NM_020376.4(PNPLA2):c.690G>A (p.Glu230=) | Neutral lipid storage myopathy [RCV005082323] | likely benign | 11 | 822600 | 822600 | Human | 1 | name |
| 597891599 | CV3763025 | single nucleotide variant | NM_020376.4(PNPLA2):c.900G>T (p.Leu300=) | Neutral lipid storage myopathy [RCV005110798] | likely benign | 11 | 823836 | 823836 | Human | 1 | name |
| 597874451 | CV3766145 | single nucleotide variant | NM_020376.4(PNPLA2):c.897C>T (p.His299=) | Neutral lipid storage myopathy [RCV005108277] | likely benign | 11 | 823833 | 823833 | Human | 1 | name |
| 597894181 | CV3833436 | single nucleotide variant | NM_020376.4(PNPLA2):c.543C>A (p.Thr181=) | Neutral lipid storage myopathy [RCV005180128] | likely benign | 11 | 822453 | 822453 | Human | 1 | name |
| 597919035 | CV3842527 | single nucleotide variant | NM_020376.4(PNPLA2):c.363G>A (p.Val121=) | Neutral lipid storage myopathy [RCV005184012] | likely benign | 11 | 821803 | 821803 | Human | 1 | name |
| 597905896 | CV3846628 | single nucleotide variant | NM_020376.4(PNPLA2):c.933C>T (p.Ala311=) | Neutral lipid storage myopathy [RCV005182055] | likely benign | 11 | 824011 | 824011 | Human | 1 | name |
| 597870986 | CV3849246 | single nucleotide variant | NM_020376.4(PNPLA2):c.645C>T (p.Asn215=) | Neutral lipid storage myopathy [RCV005197427] | likely benign | 11 | 822555 | 822555 | Human | 1 | name |
| 597929198 | CV3862832 | single nucleotide variant | NM_020376.4(PNPLA2):c.900G>A (p.Leu300=) | Neutral lipid storage myopathy [RCV005206366] | likely benign | 11 | 823836 | 823836 | Human | 1 | name |
| 13494570 | CV461471 | single nucleotide variant | NM_020376.4(PNPLA2):c.85C>T (p.Leu29Phe) | Inborn genetic diseases [RCV004955640]|Neutral lipid storage myopathy [RCV000536494] | uncertain significance | 11 | 819803 | 819803 | Human | 2 | name |
| 13473819 | CV461479 | single nucleotide variant | NM_020376.4(PNPLA2):c.873C>A (p.Pro291=) | Neutral lipid storage myopathy [RCV000525549] | likely benign | 11 | 823809 | 823809 | Human | 1 | name |
| 13469686 | CV462009 | single nucleotide variant | NM_020376.4(PNPLA2):c.435C>T (p.Ser145=) | Neutral lipid storage myopathy [RCV000545559] | likely benign | 11 | 821972 | 821972 | Human | 1 | name |
| 13475810 | CV462313 | single nucleotide variant | NM_020376.4(PNPLA2):c.360C>T (p.Arg120=) | Neutral lipid storage myopathy [RCV000526453]|PNPLA2-related disorder [RCV003900176] | likely benign | 11 | 821800 | 821800 | Human | 2 | name , trait , alternate_id |
| 15141872 | CV687830 | single nucleotide variant | NM_020376.4(PNPLA2):c.492C>T (p.Tyr164=) | Neutral lipid storage myopathy [RCV000865436]|not provided [RCV001779090] | likely benign|conflicting interpretations of pathogenicity | 11 | 822402 | 822402 | Human | 1 | name |
| 15104522 | CV687831 | single nucleotide variant | NM_020376.4(PNPLA2):c.726C>T (p.Tyr242=) | Neutral lipid storage myopathy [RCV001114384] | likely benign|conflicting interpretations of pathogenicity|uncertain significance | 11 | 823556 | 823556 | Human | 1 | name |
| 15113283 | CV693117 | single nucleotide variant | NM_020376.4(PNPLA2):c.528T>C (p.Tyr176=) | Neutral lipid storage myopathy [RCV001493891] | likely benign | 11 | 822438 | 822438 | Human | 1 | name |
| 15144812 | CV693118 | single nucleotide variant | NM_020376.4(PNPLA2):c.918G>A (p.Glu306=) | Neutral lipid storage myopathy [RCV000878280]|PNPLA2-related disorder [RCV003967952]|not provided [RCV003884780] | likely benign | 11 | 823854 | 823854 | Human | 2 | name , trait , alternate_id |
| 15188459 | CV702010 | single nucleotide variant | NM_020376.4(PNPLA2):c.396C>T (p.Phe132=) | Neutral lipid storage myopathy [RCV001403700] | likely benign | 11 | 821836 | 821836 | Human | 1 | name |
| 15180989 | CV702011 | single nucleotide variant | NM_020376.4(PNPLA2):c.597C>T (p.Ser199=) | Neutral lipid storage myopathy [RCV000951875] | likely benign|conflicting interpretations of pathogenicity | 11 | 822507 | 822507 | Human | 1 | name |
| 15167872 | CV702012 | single nucleotide variant | NM_020376.4(PNPLA2):c.789G>C (p.Ala263=) | Neutral lipid storage myopathy [RCV000949141] | likely benign | 11 | 823725 | 823725 | Human | 1 | name |
| 15105605 | CV724772 | single nucleotide variant | NM_020376.4(PNPLA2):c.966C>T (p.Leu322=) | not provided [RCV000893113] | likely benign | 11 | 824044 | 824044 | Human | | name |
| 15191089 | CV738334 | single nucleotide variant | NM_020376.4(PNPLA2):c.462C>T (p.Leu154=) | Neutral lipid storage myopathy [RCV000910145] | likely benign | 11 | 821999 | 821999 | Human | 1 | name |
| 15199332 | CV768815 | single nucleotide variant | NM_020376.4(PNPLA2):c.447C>T (p.Pro149=) | Neutral lipid storage myopathy [RCV001438605] | likely benign | 11 | 821984 | 821984 | Human | 1 | name |
| 15194742 | CV768816 | single nucleotide variant | NM_020376.4(PNPLA2):c.669C>T (p.Ser223=) | not provided [RCV000933729] | likely benign | 11 | 822579 | 822579 | Human | | name |
| 15127520 | CV784231 | single nucleotide variant | NM_020376.4(PNPLA2):c.471C>A (p.Pro157=) | not provided [RCV000980559] | likely benign | 11 | 822008 | 822008 | Human | | name |
| 26917264 | CV839117 | single nucleotide variant | NM_020376.4(PNPLA2):c.372C>T (p.Gly124=) | Neutral lipid storage myopathy [RCV001056894] | uncertain significance | 11 | 821812 | 821812 | Human | 1 | name |
| 26891846 | CV839119 | single nucleotide variant | NM_020376.4(PNPLA2):c.564G>A (p.Ser188=) | Neutral lipid storage myopathy [RCV001068425] | uncertain significance | 11 | 822474 | 822474 | Human | 1 | name |
| 26922726 | CV839121 | single nucleotide variant | NM_020376.4(PNPLA2):c.735C>T (p.Gly245=) | Neutral lipid storage myopathy [RCV001062630] | likely benign|uncertain significance | 11 | 823565 | 823565 | Human | 1 | name |
| 28911695 | CV868874 | single nucleotide variant | NM_020376.4(PNPLA2):c.444C>T (p.Ile148=) | Neutral lipid storage myopathy [RCV001111016] | uncertain significance | 11 | 821981 | 821981 | Human | 1 | name |
| 28869198 | CV868876 | single nucleotide variant | NM_020376.4(PNPLA2):c.717G>A (p.Lys239=) | Neutral lipid storage myopathy [RCV001113012] | uncertain significance | 11 | 823547 | 823547 | Human | 1 | name |
| 38486963 | CV926402 | single nucleotide variant | NM_020376.4(PNPLA2):c.62A>G (p.Tyr21Cys) | Neutral lipid storage myopathy [RCV001220544] | uncertain significance | 11 | 819780 | 819780 | Human | 1 | name |
| 38467749 | CV947720 | single nucleotide variant | NM_020376.4(PNPLA2):c.40G>A (p.Gly14Ser) | Neutral lipid storage myopathy [RCV001230482] | uncertain significance | 11 | 819758 | 819758 | Human | 1 | name |
| 39456877 | CV965653 | single nucleotide variant | NM_020376.4(PNPLA2):c.32C>T (p.Ser11Leu) | Abnormality of the musculature [RCV001814293]|Neutral lipid storage myopathy [RCV001255207] | likely pathogenic | 11 | 819750 | 819750 | Human | 3 | name |
| 126736298 | CV1020954 | single nucleotide variant | NM_020376.4(PNPLA2):c.161C>G (p.Thr54Arg) | Neutral lipid storage myopathy [RCV001335050] | uncertain significance | 11 | 819879 | 819879 | Human | 1 | name |
| 126913777 | CV1047579 | single nucleotide variant | NM_020376.4(PNPLA2):c.247C>G (p.Pro83Ala) | Neutral lipid storage myopathy [RCV001359302] | uncertain significance | 11 | 821687 | 821687 | Human | 1 | name |
| 127233574 | CV1062537 | deletion | NM_020376.4(PNPLA2):c.792del (p.Leu264fs) | Neutral lipid storage myopathy [RCV001381728] | pathogenic|likely pathogenic | 11 | 823728 | 823728 | Human | 1 | name |
| 127260599 | CV1078962 | single nucleotide variant | NM_020376.4(PNPLA2):c.1350C>A (p.Thr450=) | Neutral lipid storage myopathy [RCV001402214] | likely benign | 11 | 824697 | 824697 | Human | 1 | name |
| 127242556 | CV1078963 | single nucleotide variant | NM_020376.4(PNPLA2):c.1437C>T (p.His479=) | Neutral lipid storage myopathy [RCV001393359] | likely benign | 11 | 824784 | 824784 | Human | 1 | name |
| 127255978 | CV1100688 | single nucleotide variant | NM_020376.4(PNPLA2):c.1428C>T (p.Ser476=) | Neutral lipid storage myopathy [RCV001437556] | likely benign | 11 | 824775 | 824775 | Human | 1 | name |
| 127249126 | CV1100689 | single nucleotide variant | NM_020376.4(PNPLA2):c.1479C>T (p.Pro493=) | Neutral lipid storage myopathy [RCV001436029] | likely benign | 11 | 824826 | 824826 | Human | 1 | name |
| 127294819 | CV1122135 | single nucleotide variant | NM_020376.4(PNPLA2):c.1446C>G (p.Ala482=) | Neutral lipid storage myopathy [RCV001476934] | likely benign | 11 | 824793 | 824793 | Human | 1 | name |
| 127335980 | CV1143007 | single nucleotide variant | NM_020376.4(PNPLA2):c.1041C>G (p.Ser347=) | Neutral lipid storage myopathy [RCV001491850] | likely benign | 11 | 824119 | 824119 | Human | 1 | name |
| 127290205 | CV1143008 | single nucleotide variant | NM_020376.4(PNPLA2):c.1359C>T (p.Ala453=) | Neutral lipid storage myopathy [RCV001495907] | likely benign | 11 | 824706 | 824706 | Human | 1 | name |
| 151885227 | CV1444838 | deletion | NM_020376.4(PNPLA2):c.903del (p.Ala302fs) | Neutral lipid storage myopathy [RCV001941902] | pathogenic | 11 | 823837 | 823837 | Human | 1 | name |
| 151885657 | CV1445027 | deletion | NM_020376.4(PNPLA2):c.440del (p.Phe147fs) | Neutral lipid storage myopathy [RCV001941995] | pathogenic | 11 | 821975 | 821975 | Human | 1 | name |
| 151724919 | CV1452101 | single nucleotide variant | NM_020376.4(PNPLA2):c.157G>A (p.Ala53Thr) | Neutral lipid storage myopathy [RCV002040561] | uncertain significance | 11 | 819875 | 819875 | Human | 1 | name |
| 151717905 | CV1469210 | single nucleotide variant | NM_020376.4(PNPLA2):c.194C>T (p.Ala65Val) | Neutral lipid storage myopathy [RCV002039612] | uncertain significance | 11 | 821634 | 821634 | Human | 1 | name |
| 151767290 | CV1492947 | single nucleotide variant | NM_020376.4(PNPLA2):c.284G>A (p.Arg95His) | Neutral lipid storage myopathy [RCV001914633]|not provided [RCV004693851] | uncertain significance | 11 | 821724 | 821724 | Human | 1 | name |
| 152139171 | CV1533370 | single nucleotide variant | NM_020376.4(PNPLA2):c.1332G>T (p.Leu444=) | Neutral lipid storage myopathy [RCV002083922] | likely benign | 11 | 824679 | 824679 | Human | 1 | name |
| 152075106 | CV1551108 | single nucleotide variant | NM_020376.4(PNPLA2):c.1293C>T (p.Asp431=) | Neutral lipid storage myopathy [RCV002192306] | likely benign | 11 | 824640 | 824640 | Human | 1 | name |
| 152135404 | CV1560362 | single nucleotide variant | NM_020376.4(PNPLA2):c.1056G>A (p.Leu352=) | Neutral lipid storage myopathy [RCV002137473] | likely benign | 11 | 824317 | 824317 | Human | 1 | name |
| 152136003 | CV1560521 | single nucleotide variant | NM_020376.4(PNPLA2):c.1116C>T (p.Ser372=) | Neutral lipid storage myopathy [RCV002137549] | likely benign | 11 | 824377 | 824377 | Human | 1 | name |
| 152088276 | CV1577185 | single nucleotide variant | NM_020376.4(PNPLA2):c.1036C>T (p.Leu346=) | Neutral lipid storage myopathy [RCV002212366] | likely benign | 11 | 824114 | 824114 | Human | 1 | name |
| 152090525 | CV1580843 | single nucleotide variant | NM_020376.4(PNPLA2):c.1218G>T (p.Pro406=) | Neutral lipid storage myopathy [RCV002094108] | likely benign | 11 | 824565 | 824565 | Human | 1 | name |
| 152149971 | CV1601607 | single nucleotide variant | NM_020376.4(PNPLA2):c.1066C>T (p.Leu356=) | Neutral lipid storage myopathy [RCV002158029] | likely benign | 11 | 824327 | 824327 | Human | 1 | name |
| 152159719 | CV1605835 | single nucleotide variant | NM_020376.4(PNPLA2):c.1455C>T (p.Ala485=) | Neutral lipid storage myopathy [RCV002103563] | likely benign | 11 | 824802 | 824802 | Human | 1 | name |
| 152074966 | CV1620501 | single nucleotide variant | NM_020376.4(PNPLA2):c.1164C>T (p.His388=) | Neutral lipid storage myopathy [RCV002111972] | likely benign | 11 | 824425 | 824425 | Human | 1 | name |
| 152031083 | CV1632460 | single nucleotide variant | NM_020376.4(PNPLA2):c.1257G>T (p.Leu419=) | Neutral lipid storage myopathy [RCV002124474] | likely benign | 11 | 824604 | 824604 | Human | 1 | name |
| 152101480 | CV1645824 | single nucleotide variant | NM_020376.4(PNPLA2):c.1032C>T (p.Ser344=) | Neutral lipid storage myopathy [RCV002173163] | likely benign | 11 | 824110 | 824110 | Human | 1 | name |
| 152103207 | CV1656775 | single nucleotide variant | NM_020376.4(PNPLA2):c.1182G>A (p.Pro394=) | Neutral lipid storage myopathy [RCV002115617]|not provided [RCV003886561] | likely benign | 11 | 824529 | 824529 | Human | 1 | name |
| 8556518 | CV16912 | deletion | NM_020376.4(PNPLA2):c.808del (p.His270fs) | Neutral lipid storage myopathy [RCV000001950] | pathogenic | 11 | 823740 | 823740 | Human | 1 | name |
| 8556520 | CV16914 | deletion | NM_020376.4(PNPLA2):c.847del (p.Gln283fs) | Neutral lipid storage myopathy [RCV000001952] | pathogenic | 11 | 823781 | 823781 | Human | 1 | name |
| 156404261 | CV1872095 | single nucleotide variant | NM_020376.4(PNPLA2):c.1476T>G (p.Ala492=) | Neutral lipid storage myopathy [RCV003052791] | likely benign | 11 | 824823 | 824823 | Human | 1 | name |
| 156090828 | CV1895521 | single nucleotide variant | NM_020376.4(PNPLA2):c.127A>G (p.Ile43Val) | Inborn genetic diseases [RCV003161805]|Neutral lipid storage myopathy [RCV003080208] | uncertain significance | 11 | 819845 | 819845 | Human | 2 | name |
| 156413634 | CV1901020 | single nucleotide variant | NM_020376.4(PNPLA2):c.131A>G (p.Tyr44Cys) | Neutral lipid storage myopathy [RCV002588222] | uncertain significance | 11 | 819849 | 819849 | Human | 1 | name |
| 156371399 | CV1923583 | single nucleotide variant | NM_020376.4(PNPLA2):c.1191G>A (p.Val397=) | Neutral lipid storage myopathy [RCV002633417] | likely benign | 11 | 824538 | 824538 | Human | 1 | name |
| 156320310 | CV1966052 | single nucleotide variant | NM_020376.4(PNPLA2):c.283C>T (p.Arg95Cys) | Inborn genetic diseases [RCV004064586]|Neutral lipid storage myopathy [RCV002600187] | uncertain significance | 11 | 821723 | 821723 | Human | 2 | name |
| 156168774 | CV1971648 | single nucleotide variant | NM_020376.4(PNPLA2):c.1413C>G (p.Pro471=) | Neutral lipid storage myopathy [RCV002594707] | likely benign | 11 | 824760 | 824760 | Human | 1 | name |
| 155990610 | CV1990477 | single nucleotide variant | NM_020376.4(PNPLA2):c.1302C>T (p.Ala434=) | Neutral lipid storage myopathy [RCV002618004] | likely benign | 11 | 824649 | 824649 | Human | 1 | name |
| 156278049 | CV2011382 | single nucleotide variant | NM_020376.4(PNPLA2):c.1464G>A (p.Leu488=) | Neutral lipid storage myopathy [RCV002715203] | likely benign | 11 | 824811 | 824811 | Human | 1 | name |
| 156122303 | CV2039923 | single nucleotide variant | NM_020376.4(PNPLA2):c.1128C>T (p.Tyr376=) | Neutral lipid storage myopathy [RCV002785839] | likely benign | 11 | 824389 | 824389 | Human | 1 | name |
| 156229669 | CV2048617 | single nucleotide variant | NM_020376.4(PNPLA2):c.1074C>T (p.Asp358=) | Neutral lipid storage myopathy [RCV002790948] | likely benign | 11 | 824335 | 824335 | Human | 1 | name |
| 155998956 | CV2057307 | single nucleotide variant | NM_020376.4(PNPLA2):c.1227G>A (p.Pro409=) | Neutral lipid storage myopathy [RCV002819555] | likely benign | 11 | 824574 | 824574 | Human | 1 | name |
| 155958081 | CV2066545 | single nucleotide variant | NM_020376.4(PNPLA2):c.1203C>T (p.Arg401=) | Neutral lipid storage myopathy [RCV002816630] | likely benign | 11 | 824550 | 824550 | Human | 1 | name |
| 155932451 | CV2096157 | single nucleotide variant | NM_020376.4(PNPLA2):c.1375C>T (p.Leu459=) | Neutral lipid storage myopathy [RCV002903905] | likely benign | 11 | 824722 | 824722 | Human | 1 | name |
| 156309681 | CV2109454 | single nucleotide variant | NM_020376.4(PNPLA2):c.1338C>T (p.Gly446=) | Neutral lipid storage myopathy [RCV002922999] | likely benign | 11 | 824685 | 824685 | Human | 1 | name |
| 156213364 | CV2110790 | single nucleotide variant | NM_020376.4(PNPLA2):c.1212G>A (p.Ser404=) | Neutral lipid storage myopathy [RCV002918255] | likely benign | 11 | 824559 | 824559 | Human | 1 | name |
| 156113751 | CV2154355 | single nucleotide variant | NM_020376.4(PNPLA2):c.1122C>T (p.Cys374=) | Neutral lipid storage myopathy [RCV003021519] | likely benign | 11 | 824383 | 824383 | Human | 1 | name |
| 156222431 | CV2173353 | single nucleotide variant | NM_020376.4(PNPLA2):c.1365G>T (p.Pro455=) | Neutral lipid storage myopathy [RCV003025247] | likely benign | 11 | 824712 | 824712 | Human | 1 | name |
| 156244507 | CV2187304 | single nucleotide variant | NM_020376.4(PNPLA2):c.226G>A (p.Ala76Thr) | Neutral lipid storage myopathy [RCV003059779] | uncertain significance | 11 | 821666 | 821666 | Human | 1 | name |
| 243059593 | CV2413425 | single nucleotide variant | NM_020376.4(PNPLA2):c.260C>T (p.Ser87Phe) | Neutral lipid storage myopathy [RCV003135059] | uncertain significance | 11 | 821700 | 821700 | Human | 1 | name |
| 243059594 | CV2413426 | single nucleotide variant | NM_020376.4(PNPLA2):c.229C>T (p.Arg77Trp) | Neutral lipid storage myopathy [RCV003135060] | uncertain significance | 11 | 821669 | 821669 | Human | 1 | name |
| 243059603 | CV2413432 | single nucleotide variant | NM_020376.4(PNPLA2):c.279C>G (p.Ile93Met) | Neutral lipid storage myopathy [RCV003135065] | uncertain significance | 11 | 821719 | 821719 | Human | 1 | name |
| 11548647 | CV254351 | single nucleotide variant | NM_020376.4(PNPLA2):c.1149G>A (p.Arg383=) | Neutral lipid storage myopathy [RCV000292101]|not provided [RCV001706355]|not specified [RCV000249362] | benign|likely benign|conflicting interpretations of pathogenicity | 11 | 824410 | 824410 | Human | 2 | name |
| 11548647 | CV254351 | single nucleotide variant | NM_020376.4(PNPLA2):c.1149G>A (p.Arg383=) | Neutral lipid storage myopathy [RCV000292101]|not provided [RCV001706355]|not specified [RCV000249362] | benign|likely benign|conflicting interpretations of pathogenicity | 11 | 824410 | 824411 | Human | 2 | name |
| 11552113 | CV254352 | single nucleotide variant | NM_020376.4(PNPLA2):c.1167G>T (p.Leu389=) | Neutral lipid storage myopathy [RCV000325948]|not provided [RCV001651239]|not specified [RCV000253941] | benign | 11 | 824428 | 824428 | Human | 1 | name |
| 11546856 | CV254358 | single nucleotide variant | NM_020376.4(PNPLA2):c.1458C>T (p.Pro486=) | Neutral lipid storage myopathy [RCV000408396]|not provided [RCV000831839]|not specified [RCV000247006] | benign | 11 | 824805 | 824805 | Human | 4 | name |
| 11546856 | CV254358 | single nucleotide variant | NM_020376.4(PNPLA2):c.1458C>T (p.Pro486=) | Neutral lipid storage myopathy [RCV000408396]|not provided [RCV000831839]|not specified [RCV000247006] | benign | 11 | 824805 | 824806 | Human | 4 | name |
| 401907814 | CV2806412 | single nucleotide variant | NM_020376.4(PNPLA2):c.1335C>G (p.Leu445=) | Neutral lipid storage myopathy [RCV003778376]|not provided [RCV003422925] | likely benign | 11 | 824682 | 824682 | Human | 1 | name |
| 405108779 | CV2874159 | single nucleotide variant | NM_020376.4(PNPLA2):c.1041C>T (p.Ser347=) | Neutral lipid storage myopathy [RCV003498884] | likely benign | 11 | 824119 | 824119 | Human | 1 | name |
| 405115247 | CV2894075 | single nucleotide variant | NM_020376.4(PNPLA2):c.1404T>C (p.Ala468=) | Neutral lipid storage myopathy [RCV003499857] | likely benign | 11 | 824751 | 824751 | Human | 1 | name |
| 405027144 | CV2964044 | single nucleotide variant | NM_020376.4(PNPLA2):c.1446C>T (p.Ala482=) | Neutral lipid storage myopathy [RCV003601452] | likely benign | 11 | 824793 | 824793 | Human | 1 | name |
| 405022241 | CV3049028 | single nucleotide variant | NM_020376.4(PNPLA2):c.1395C>G (p.Ala465=) | Neutral lipid storage myopathy [RCV003600990] | likely benign | 11 | 824742 | 824742 | Human | 1 | name |
| 405023226 | CV3061027 | single nucleotide variant | NM_020376.4(PNPLA2):c.245G>A (p.Gly82Asp) | Neutral lipid storage myopathy [RCV003601109] | pathogenic|likely pathogenic | 11 | 821685 | 821685 | Human | 1 | name |
| 405033504 | CV3079169 | single nucleotide variant | NM_020376.4(PNPLA2):c.1413C>A (p.Pro471=) | Neutral lipid storage myopathy [RCV003601879] | likely benign | 11 | 824760 | 824760 | Human | 1 | name |
| 405168271 | CV3149809 | single nucleotide variant | NM_020376.4(PNPLA2):c.182G>T (p.Cys61Phe) | Neutral lipid storage myopathy [RCV003841280] | uncertain significance | 11 | 819900 | 819900 | Human | 1 | name |
| 405243979 | CV3161077 | single nucleotide variant | NM_020376.4(PNPLA2):c.1278C>T (p.Asn426=) | Neutral lipid storage myopathy [RCV003867986] | likely benign | 11 | 824625 | 824625 | Human | 1 | name |
| 596925597 | CV3542064 | deletion | NM_020376.4(PNPLA2):c.907del (p.Arg303fs) | Neutral lipid storage myopathy [RCV004795780] | likely pathogenic | 11 | 823841 | 823841 | Human | 1 | name |
| 597692030 | CV3590663 | single nucleotide variant | NM_020376.4(PNPLA2):c.164C>T (p.Ala55Val) | Inborn genetic diseases [RCV004954290] | uncertain significance | 11 | 819882 | 819882 | Human | 1 | name |
| 597939408 | CV3788532 | deletion | NM_020376.4(PNPLA2):c.875del (p.Gly292fs) | Neutral lipid storage myopathy [RCV005133207] | pathogenic | 11 | 823810 | 823810 | Human | 1 | name |
| 597903180 | CV3835879 | single nucleotide variant | NM_020376.4(PNPLA2):c.1434G>A (p.Gln478=) | Neutral lipid storage myopathy [RCV005181414] | likely benign | 11 | 824781 | 824781 | Human | 1 | name |
| 597925682 | CV3840031 | single nucleotide variant | NM_020376.4(PNPLA2):c.1374T>G (p.Ala458=) | Neutral lipid storage myopathy [RCV005184770] | likely benign | 11 | 824721 | 824721 | Human | 1 | name |
| 597944611 | CV3847924 | single nucleotide variant | NM_020376.4(PNPLA2):c.1287G>A (p.Leu429=) | Neutral lipid storage myopathy [RCV005188654] | likely benign | 11 | 824634 | 824634 | Human | 1 | name |
| 597949445 | CV3848770 | single nucleotide variant | NM_020376.4(PNPLA2):c.1209G>A (p.Gln403=) | Neutral lipid storage myopathy [RCV005189707] | likely benign | 11 | 824556 | 824556 | Human | 1 | name |
| 597860372 | CV3860033 | single nucleotide variant | NM_020376.4(PNPLA2):c.132C>G (p.Tyr44Ter) | Neutral lipid storage myopathy [RCV005195762] | pathogenic | 11 | 819850 | 819850 | Human | 1 | name |
| 13481218 | CV461474 | single nucleotide variant | NM_020376.4(PNPLA2):c.236G>A (p.Arg79Gln) | Neutral lipid storage myopathy [RCV000528874] | conflicting interpretations of pathogenicity|uncertain significance | 11 | 821676 | 821676 | Human | 1 | name |
| 13466610 | CV461682 | single nucleotide variant | NM_020376.4(PNPLA2):c.128T>G (p.Ile43Ser) | Neutral lipid storage myopathy [RCV000543540] | uncertain significance | 11 | 819846 | 819846 | Human | 1 | name |
| 13479307 | CV462008 | single nucleotide variant | NM_020376.4(PNPLA2):c.235C>T (p.Arg79Trp) | Inborn genetic diseases [RCV002525304]|Neutral lipid storage myopathy [RCV000550462] | uncertain significance | 11 | 821675 | 821675 | Human | 2 | name |
| 8570687 | CV48467 | deletion | NM_020376.4(PNPLA2):c.467del (p.Pro156fs) | Neutral lipid storage myopathy [RCV000033095] | pathogenic | 11 | 822002 | 822002 | Human | 1 | name |
| 13611059 | CV526503 | single nucleotide variant | NM_020376.4(PNPLA2):c.1491C>T (p.Pro497=) | Neutral lipid storage myopathy [RCV000641669] | likely benign|conflicting interpretations of pathogenicity | 11 | 824838 | 824838 | Human | 1 | name |
| 13611038 | CV526791 | single nucleotide variant | NM_020376.4(PNPLA2):c.256C>T (p.Pro86Ser) | Neutral lipid storage myopathy [RCV000641661] | uncertain significance | 11 | 821696 | 821696 | Human | 1 | name |
| 13806588 | CV567558 | single nucleotide variant | NM_020376.4(PNPLA2):c.122C>A (p.Thr41Lys) | Neutral lipid storage myopathy [RCV000686320] | uncertain significance | 11 | 819840 | 819840 | Human | 1 | name |
| 13815203 | CV571010 | single nucleotide variant | NM_020376.4(PNPLA2):c.291C>A (p.Phe97Leu) | Neutral lipid storage myopathy [RCV000705552] | uncertain significance | 11 | 821731 | 821731 | Human | 1 | name |
| 14728352 | CV640480 | single nucleotide variant | NM_020376.4(PNPLA2):c.178G>A (p.Val60Ile) | Neutral lipid storage myopathy [RCV000816479] | uncertain significance | 11 | 819896 | 819896 | Human | 1 | name |
| 14707312 | CV640487 | single nucleotide variant | NM_020376.4(PNPLA2):c.1395C>A (p.Ala465=) | Neutral lipid storage myopathy [RCV000792288] | likely benign|uncertain significance | 11 | 824742 | 824742 | Human | 1 | name |
| 15142766 | CV713220 | single nucleotide variant | NM_020376.4(PNPLA2):c.1368C>T (p.Pro456=) | Neutral lipid storage myopathy [RCV001407325] | likely benign | 11 | 824715 | 824715 | Human | 1 | name |
| 15141172 | CV753004 | single nucleotide variant | NM_020376.4(PNPLA2):c.1260C>T (p.Pro420=) | Inborn genetic diseases [RCV005392550]|Neutral lipid storage myopathy [RCV001466275] | likely benign | 11 | 824607 | 824607 | Human | 2 | name |
| 15195322 | CV753005 | single nucleotide variant | NM_020376.4(PNPLA2):c.1419C>T (p.Asp473=) | Neutral lipid storage myopathy [RCV000911382] | likely benign | 11 | 824766 | 824766 | Human | 1 | name |
| 8573216 | CV76349 | duplication | NM_020376.4(PNPLA2):c.613dup (p.Leu205fs) | Inborn genetic diseases [RCV000624438]|Neutral lipid storage myopathy [RCV000055641]|not provided [RCV001091425] | pathogenic | 11 | 822522 | 822523 | Human | 2 | name |
| 8573217 | CV76350 | deletion | NM_020376.4(PNPLA2):c.543del (p.Ile182fs) | Neutral lipid storage myopathy [RCV000055642] | pathogenic | 11 | 822452 | 822452 | Human | 1 | name |
| 15172206 | CV768817 | single nucleotide variant | NM_020376.4(PNPLA2):c.1101G>A (p.Lys367=) | Neutral lipid storage myopathy [RCV000928064] | likely benign | 11 | 824362 | 824362 | Human | 1 | name |
| 15187483 | CV768818 | single nucleotide variant | NM_020376.4(PNPLA2):c.1194G>A (p.Glu398=) | Neutral lipid storage myopathy [RCV001413157] | likely benign | 11 | 824541 | 824541 | Human | 1 | name |
| 15187952 | CV768819 | single nucleotide variant | NM_020376.4(PNPLA2):c.1248A>G (p.Arg416=) | Neutral lipid storage myopathy [RCV001419372] | likely benign | 11 | 824595 | 824595 | Human | 1 | name |
| 15187491 | CV768820 | single nucleotide variant | NM_020376.4(PNPLA2):c.1320G>A (p.Gln440=) | Neutral lipid storage myopathy [RCV000931673] | likely benign | 11 | 824667 | 824667 | Human | 1 | name |
| 15102095 | CV784232 | single nucleotide variant | NM_020376.4(PNPLA2):c.1047C>T (p.Thr349=) | Neutral lipid storage myopathy [RCV001494004] | likely benign | 11 | 824125 | 824125 | Human | 1 | name |
| 15127400 | CV784233 | single nucleotide variant | NM_020376.4(PNPLA2):c.1161G>A (p.Arg387=) | not provided [RCV000980540] | likely benign | 11 | 824422 | 824422 | Human | | name |
| 15136512 | CV784234 | single nucleotide variant | NM_020376.4(PNPLA2):c.1392C>T (p.Pro464=) | Neutral lipid storage myopathy [RCV001418026] | likely benign | 11 | 824739 | 824739 | Human | 1 | name |
| 26918267 | CV839116 | single nucleotide variant | NM_020376.4(PNPLA2):c.230G>A (p.Arg77Gln) | Neutral lipid storage myopathy [RCV001057710] | uncertain significance | 11 | 821670 | 821670 | Human | 1 | name |
| 28883486 | CV859916 | deletion | NM_020376.4(PNPLA2):c.799del (p.Ala267fs) | not provided [RCV001091426] | pathogenic | 11 | 823735 | 823735 | Human | | name |
| 38474157 | CV926405 | duplication | NM_020376.4(PNPLA2):c.798dup (p.Ala267fs) | Neutral lipid storage myopathy [RCV001214622]|not provided [RCV005411678] | pathogenic | 11 | 823728 | 823729 | Human | 1 | name |
| 126753962 | CV1010032 | single nucleotide variant | NM_020376.4(PNPLA2):c.480G>C (p.Gln160His) | Neutral lipid storage myopathy [RCV001327402] | uncertain significance | 11 | 822017 | 822017 | Human | 1 | name |
| 126743987 | CV1010033 | single nucleotide variant | NM_020376.4(PNPLA2):c.704G>A (p.Arg235Gln) | Neutral lipid storage myopathy [RCV001325700] | uncertain significance | 11 | 823534 | 823534 | Human | 1 | name |
| 126764185 | CV1010035 | single nucleotide variant | NM_020376.4(PNPLA2):c.914A>G (p.Asn305Ser) | Neutral lipid storage myopathy [RCV001319537] | uncertain significance | 11 | 823850 | 823850 | Human | 1 | name |
| 126744570 | CV1030574 | single nucleotide variant | NM_020376.4(PNPLA2):c.649C>A (p.Arg217Ser) | Neutral lipid storage myopathy [RCV001351297] | uncertain significance | 11 | 822559 | 822559 | Human | 1 | name |
| 126738276 | CV1030575 | single nucleotide variant | NM_020376.4(PNPLA2):c.681C>G (p.Phe227Leu) | Neutral lipid storage myopathy [RCV001350456] | uncertain significance | 11 | 822591 | 822591 | Human | 1 | name |
| 126748958 | CV1030576 | single nucleotide variant | NM_020376.4(PNPLA2):c.908G>A (p.Arg303Gln) | Neutral lipid storage myopathy [RCV001337755] | uncertain significance | 11 | 823844 | 823844 | Human | 1 | name |
| 126920422 | CV1047580 | single nucleotide variant | NM_020376.4(PNPLA2):c.409G>A (p.Glu137Lys) | Neutral lipid storage myopathy [RCV001362867] | uncertain significance | 11 | 821849 | 821849 | Human | 1 | name |
| 151349090 | CV1170271 | duplication | NM_020376.4(PNPLA2):c.1343dup (p.Cys449fs) | Abnormality of the musculature [RCV001814421] | likely pathogenic | 11 | 824688 | 824689 | Human | 1 | name |
| 151771873 | CV1346268 | single nucleotide variant | NM_020376.4(PNPLA2):c.320A>G (p.His107Arg) | Neutral lipid storage myopathy [RCV001950236] | uncertain significance | 11 | 821760 | 821760 | Human | 1 | name |
| 151852777 | CV1349120 | single nucleotide variant | NM_020376.4(PNPLA2):c.826G>A (p.Asp276Asn) | Neutral lipid storage myopathy [RCV001923017] | uncertain significance | 11 | 823762 | 823762 | Human | 1 | name |
| 151758725 | CV1349876 | single nucleotide variant | NM_020376.4(PNPLA2):c.815C>G (p.Pro272Arg) | Neutral lipid storage myopathy [RCV001987014]|PNPLA2-related disorder [RCV003402027] | uncertain significance | 11 | 823751 | 823751 | Human | 2 | name , trait , alternate_id |
| 151712142 | CV1374463 | single nucleotide variant | NM_020376.4(PNPLA2):c.944C>G (p.Pro315Arg) | Neutral lipid storage myopathy [RCV001908232] | uncertain significance | 11 | 824022 | 824022 | Human | 1 | name |
| 151843210 | CV1379847 | single nucleotide variant | NM_020376.4(PNPLA2):c.973A>C (p.Met325Leu) | Inborn genetic diseases [RCV002560601]|Neutral lipid storage myopathy [RCV001936370] | uncertain significance | 11 | 824051 | 824051 | Human | 2 | name |
| 151882512 | CV1398977 | single nucleotide variant | NM_020376.4(PNPLA2):c.358C>T (p.Arg120Cys) | Neutral lipid storage myopathy [RCV001961936] | uncertain significance | 11 | 821798 | 821798 | Human | 1 | name |
| 151772926 | CV1401272 | single nucleotide variant | NM_020376.4(PNPLA2):c.851C>G (p.Ala284Gly) | Neutral lipid storage myopathy [RCV002025536] | uncertain significance | 11 | 823787 | 823787 | Human | 1 | name |
| 151772480 | CV1402683 | single nucleotide variant | NM_020376.4(PNPLA2):c.856G>A (p.Asp286Asn) | Neutral lipid storage myopathy [RCV001896477]|not provided [RCV004793575] | uncertain significance | 11 | 823792 | 823792 | Human | 1 | name |
| 151859676 | CV1403694 | single nucleotide variant | NM_020376.4(PNPLA2):c.359G>A (p.Arg120His) | Inborn genetic diseases [RCV004955974]|Neutral lipid storage myopathy [RCV001979964] | uncertain significance | 11 | 821799 | 821799 | Human | 2 | name |
| 151738909 | CV1428921 | single nucleotide variant | NM_020376.4(PNPLA2):c.524T>A (p.Leu175His) | Neutral lipid storage myopathy [RCV002022125] | uncertain significance | 11 | 822434 | 822434 | Human | 1 | name |
| 151875482 | CV1461252 | single nucleotide variant | NM_020376.4(PNPLA2):c.992C>T (p.Ala331Val) | Neutral lipid storage myopathy [RCV001925764]|not provided [RCV004697161] | uncertain significance | 11 | 824070 | 824070 | Human | 1 | name |
| 151770986 | CV1465109 | single nucleotide variant | NM_020376.4(PNPLA2):c.448G>T (p.Val150Leu) | Neutral lipid storage myopathy [RCV002025353] | uncertain significance | 11 | 821985 | 821985 | Human | 1 | name |
| 151834149 | CV1489027 | single nucleotide variant | NM_020376.4(PNPLA2):c.662G>A (p.Arg221His) | Neutral lipid storage myopathy [RCV001902106]|not provided [RCV002243477] | uncertain significance | 11 | 822572 | 822572 | Human | 1 | name |
| 151819645 | CV1490526 | single nucleotide variant | NM_020376.4(PNPLA2):c.470C>T (p.Pro157Leu) | Neutral lipid storage myopathy [RCV001992642] | uncertain significance | 11 | 822007 | 822007 | Human | 1 | name |
| 151715112 | CV1492922 | single nucleotide variant | NM_020376.4(PNPLA2):c.437G>T (p.Gly146Val) | Neutral lipid storage myopathy [RCV001890175] | uncertain significance | 11 | 821974 | 821974 | Human | 1 | name |
| 151839598 | CV1492953 | single nucleotide variant | NM_020376.4(PNPLA2):c.385A>G (p.Ile129Val) | Neutral lipid storage myopathy [RCV001881181] | uncertain significance | 11 | 821825 | 821825 | Human | 1 | name |
| 151864159 | CV1498689 | single nucleotide variant | NM_020376.4(PNPLA2):c.449T>G (p.Val150Gly) | Neutral lipid storage myopathy [RCV001980513] | uncertain significance | 11 | 821986 | 821986 | Human | 1 | name |
| 151773136 | CV1502221 | single nucleotide variant | NM_020376.4(PNPLA2):c.890T>C (p.Leu297Pro) | Neutral lipid storage myopathy [RCV001929725] | uncertain significance | 11 | 823826 | 823826 | Human | 1 | name |
| 151843030 | CV1514552 | single nucleotide variant | NM_020376.4(PNPLA2):c.568G>A (p.Glu190Lys) | Neutral lipid storage myopathy [RCV001956987] | uncertain significance | 11 | 822478 | 822478 | Human | 1 | name |
| 8556519 | CV16913 | single nucleotide variant | NM_020376.4(PNPLA2):c.584C>T (p.Pro195Leu) | Neutral lipid storage myopathy [RCV000001951] | pathogenic | 11 | 822494 | 822494 | Human | 1 | name |
| 8556521 | CV16915 | single nucleotide variant | NM_020376.4(PNPLA2):c.865C>T (p.Gln289Ter) | Neutral lipid storage myopathy [RCV000001953] | pathogenic | 11 | 823801 | 823801 | Human | 1 | name |
| 155727226 | CV1773736 | single nucleotide variant | NM_020376.4(PNPLA2):c.749A>G (p.Gln250Arg) | Neutral lipid storage myopathy [RCV002301514] | uncertain significance | 11 | 823579 | 823579 | Human | 1 | name |
| 155734610 | CV1774410 | single nucleotide variant | NM_020376.4(PNPLA2):c.886A>G (p.Ile296Val) | Neutral lipid storage myopathy [RCV002301866] | uncertain significance | 11 | 823822 | 823822 | Human | 1 | name |
| 155708538 | CV1775691 | single nucleotide variant | NM_020376.4(PNPLA2):c.799G>A (p.Ala267Thr) | Neutral lipid storage myopathy [RCV002296087] | uncertain significance | 11 | 823735 | 823735 | Human | 1 | name |
| 156308397 | CV1877950 | single nucleotide variant | NM_020376.4(PNPLA2):c.497A>G (p.Asp166Gly) | Neutral lipid storage myopathy [RCV003062309]|not provided [RCV004719289] | likely pathogenic|uncertain significance | 11 | 822407 | 822407 | Human | 1 | name |
| 156308414 | CV1877951 | single nucleotide variant | NM_020376.4(PNPLA2):c.778C>G (p.Pro260Ala) | Neutral lipid storage myopathy [RCV003062310] | uncertain significance | 11 | 823714 | 823714 | Human | 1 | name |
| 156406817 | CV1891369 | single nucleotide variant | NM_020376.4(PNPLA2):c.785T>G (p.Leu262Arg) | Inborn genetic diseases [RCV005399099]|Neutral lipid storage myopathy [RCV003070509] | uncertain significance | 11 | 823721 | 823721 | Human | 2 | name |
| 156194471 | CV1900553 | single nucleotide variant | NM_020376.4(PNPLA2):c.947C>T (p.Thr316Met) | Neutral lipid storage myopathy [RCV002574522] | uncertain significance | 11 | 824025 | 824025 | Human | 1 | name |
| 156200779 | CV1915555 | single nucleotide variant | NM_020376.4(PNPLA2):c.918G>C (p.Glu306Asp) | Neutral lipid storage myopathy [RCV002643625] | uncertain significance | 11 | 823854 | 823854 | Human | 1 | name |
| 156414032 | CV1915616 | single nucleotide variant | NM_020376.4(PNPLA2):c.875G>A (p.Gly292Glu) | Inborn genetic diseases [RCV003269473]|Neutral lipid storage myopathy [RCV002588365] | uncertain significance | 11 | 823811 | 823811 | Human | 2 | name |
| 156131924 | CV1962750 | single nucleotide variant | NM_020376.4(PNPLA2):c.686C>T (p.Pro229Leu) | Neutral lipid storage myopathy [RCV002572264] | uncertain significance | 11 | 822596 | 822596 | Human | 1 | name |
| 155972433 | CV1978564 | single nucleotide variant | NM_020376.4(PNPLA2):c.650G>T (p.Arg217Leu) | Neutral lipid storage myopathy [RCV002617242] | uncertain significance | 11 | 822560 | 822560 | Human | 1 | name |
| 156363771 | CV2003404 | single nucleotide variant | NM_020376.4(PNPLA2):c.968C>G (p.Ser323Cys) | Neutral lipid storage myopathy [RCV002676420] | uncertain significance | 11 | 824046 | 824046 | Human | 1 | name |
| 156396289 | CV2012342 | single nucleotide variant | NM_020376.4(PNPLA2):c.448G>C (p.Val150Leu) | Neutral lipid storage myopathy [RCV002725577] | uncertain significance | 11 | 821985 | 821985 | Human | 1 | name |
| 155904307 | CV2031326 | single nucleotide variant | NM_020376.4(PNPLA2):c.770G>A (p.Arg257Gln) | Neutral lipid storage myopathy [RCV002726374] | uncertain significance | 11 | 823706 | 823706 | Human | 1 | name |
| 156069884 | CV2032560 | single nucleotide variant | NM_020376.4(PNPLA2):c.341T>C (p.Leu114Pro) | Neutral lipid storage myopathy [RCV002760288] | uncertain significance | 11 | 821781 | 821781 | Human | 1 | name |
| 156009133 | CV2051303 | single nucleotide variant | NM_020376.4(PNPLA2):c.769C>T (p.Arg257Trp) | Neutral lipid storage myopathy [RCV002820027] | uncertain significance | 11 | 823705 | 823705 | Human | 1 | name |
| 155934671 | CV2064363 | duplication | NM_020376.4(PNPLA2):c.1120dup (p.Cys374fs) | Neutral lipid storage myopathy [RCV002861349] | uncertain significance | 11 | 824380 | 824381 | Human | 1 | name |
| 155990120 | CV2066761 | single nucleotide variant | NM_020376.4(PNPLA2):c.883C>G (p.His295Asp) | Neutral lipid storage myopathy [RCV002842923] | uncertain significance | 11 | 823819 | 823819 | Human | 1 | name |
| 156312342 | CV2107622 | single nucleotide variant | NM_020376.4(PNPLA2):c.727C>T (p.Arg243Trp) | Neutral lipid storage myopathy [RCV002937245] | uncertain significance | 11 | 823557 | 823557 | Human | 1 | name |
| 156209956 | CV2114356 | single nucleotide variant | NM_020376.4(PNPLA2):c.493G>A (p.Val165Met) | Neutral lipid storage myopathy [RCV002932020] | uncertain significance | 11 | 822403 | 822403 | Human | 1 | name |
| 156036827 | CV2119957 | single nucleotide variant | NM_020376.4(PNPLA2):c.370G>A (p.Gly124Ser) | Neutral lipid storage myopathy [RCV002949460]|PNPLA2-related disorder [RCV003427533] | uncertain significance | 11 | 821810 | 821810 | Human | 2 | name , trait , alternate_id |
| 156229728 | CV2121982 | single nucleotide variant | NM_020376.4(PNPLA2):c.389C>A (p.Ser130Tyr) | Neutral lipid storage myopathy [RCV002958462] | uncertain significance | 11 | 821829 | 821829 | Human | 1 | name |
| 155934820 | CV2129441 | single nucleotide variant | NM_020376.4(PNPLA2):c.866A>G (p.Gln289Arg) | Neutral lipid storage myopathy [RCV002970863] | uncertain significance | 11 | 823802 | 823802 | Human | 1 | name |
| 156017779 | CV2151422 | single nucleotide variant | NM_020376.4(PNPLA2):c.908G>C (p.Arg303Pro) | Neutral lipid storage myopathy [RCV003018078] | uncertain significance | 11 | 823844 | 823844 | Human | 1 | name |
| 156177522 | CV2181558 | single nucleotide variant | NM_020376.4(PNPLA2):c.937G>A (p.Val313Met) | Neutral lipid storage myopathy [RCV003057421] | uncertain significance | 11 | 824015 | 824015 | Human | 1 | name |
| 156141424 | CV2191909 | single nucleotide variant | NM_020376.4(PNPLA2):c.578T>C (p.Ile193Thr) | Neutral lipid storage myopathy [RCV003056199] | uncertain significance | 11 | 822488 | 822488 | Human | 1 | name |
| 155985762 | CV2282398 | single nucleotide variant | NM_020376.4(PNPLA2):c.488G>A (p.Arg163His) | Inborn genetic diseases [RCV002864065] | uncertain significance | 11 | 822398 | 822398 | Human | 1 | name |
| 156187910 | CV2292500 | single nucleotide variant | NM_020376.4(PNPLA2):c.822C>G (p.Asp274Glu) | Inborn genetic diseases [RCV002874062] | likely benign | 11 | 823758 | 823758 | Human | 1 | name |
| 156173911 | CV2326833 | single nucleotide variant | NM_020376.4(PNPLA2):c.752G>C (p.Arg251Pro) | Inborn genetic diseases [RCV002916713] | uncertain significance | 11 | 823582 | 823582 | Human | 1 | name |
| 243059596 | CV2413428 | single nucleotide variant | NM_020376.4(PNPLA2):c.542C>T (p.Thr181Ile) | Neutral lipid storage myopathy [RCV003135062] | uncertain significance | 11 | 822452 | 822452 | Human | 1 | name |
| 243059597 | CV2413429 | single nucleotide variant | NM_020376.4(PNPLA2):c.467C>T (p.Pro156Leu) | Neutral lipid storage myopathy [RCV003135063] | uncertain significance | 11 | 822004 | 822004 | Human | 1 | name |
| 243050544 | CV2413433 | single nucleotide variant | NM_020376.4(PNPLA2):c.975G>A (p.Met325Ile) | Neutral lipid storage myopathy [RCV003130282] | uncertain significance | 11 | 824053 | 824053 | Human | 1 | name |
| 243059602 | CV2413434 | single nucleotide variant | NM_020376.4(PNPLA2):c.982G>T (p.Val328Leu) | Neutral lipid storage myopathy [RCV003135066] | uncertain significance | 11 | 824060 | 824060 | Human | 1 | name |
| 243050547 | CV2413436 | single nucleotide variant | NM_020376.4(PNPLA2):c.665T>C (p.Leu222Pro) | Neutral lipid storage myopathy [RCV003130283] | uncertain significance | 11 | 822575 | 822575 | Human | 1 | name |
| 11526083 | CV247067 | single nucleotide variant | NM_020376.4(PNPLA2):c.793C>T (p.Pro265Ser) | Neutral lipid storage myopathy [RCV000301248]|not provided [RCV001723828]|not specified [RCV000239314] | pathogenic|benign|likely benign|conflicting interpretations of pathogenicity | 11 | 823729 | 823729 | Human | 1 | name |
| 11545027 | CV254346 | single nucleotide variant | NM_020376.4(PNPLA2):c.756C>G (p.Asn252Lys) | Neutral lipid storage myopathy [RCV000543501]|not provided [RCV001722337]|not specified [RCV000244582] | benign|likely benign | 11 | 823586 | 823586 | Human | 23 | name |
| 11551873 | CV254350 | single nucleotide variant | NM_020376.4(PNPLA2):c.943C>T (p.Pro315Ser) | Neutral lipid storage myopathy [RCV001442562]|not provided [RCV003422179]|not specified [RCV000253618] | likely benign|conflicting interpretations of pathogenicity|uncertain significance | 11 | 824021 | 824021 | Human | 1 | name |
| 401767866 | CV2677842 | single nucleotide variant | NM_020376.4(PNPLA2):c.697G>A (p.Val233Met) | Inborn genetic diseases [RCV003259950] | uncertain significance | 11 | 823527 | 823527 | Human | 1 | name |
| 401863325 | CV2776805 | single nucleotide variant | NM_020376.4(PNPLA2):c.808C>A (p.His270Asn) | Inborn genetic diseases [RCV003378508] | uncertain significance | 11 | 823744 | 823744 | Human | 1 | name |
| 401961834 | CV2844156 | single nucleotide variant | NM_020376.4(PNPLA2):c.322G>A (p.Glu108Lys) | not provided [RCV003481997] | uncertain significance | 11 | 821762 | 821762 | Human | | name |
| 405103772 | CV2895853 | single nucleotide variant | NM_020376.4(PNPLA2):c.824A>G (p.Lys275Arg) | Neutral lipid storage myopathy [RCV003497481] | uncertain significance | 11 | 823760 | 823760 | Human | 1 | name |
| 405021661 | CV3048722 | single nucleotide variant | NM_020376.4(PNPLA2):c.739C>T (p.Arg247Cys) | Neutral lipid storage myopathy [RCV003600960] | uncertain significance | 11 | 823569 | 823569 | Human | 1 | name |
| 11659021 | CV315344 | single nucleotide variant | NM_020376.4(PNPLA2):c.826G>C (p.Asp276His) | Neutral lipid storage myopathy [RCV000353802] | uncertain significance | 11 | 823762 | 823762 | Human | 1 | name |
| 11610582 | CV322205 | single nucleotide variant | NM_020376.4(PNPLA2):c.964C>T (p.Leu322Phe) | Neutral lipid storage myopathy [RCV000383623]|not provided [RCV001836764] | likely benign|conflicting interpretations of pathogenicity|uncertain significance | 11 | 824042 | 824042 | Human | 1 | name |
| 11624381 | CV328267 | single nucleotide variant | NM_020376.4(PNPLA2):c.326A>G (p.His109Arg) | Neutral lipid storage myopathy [RCV000385511]|not provided [RCV004693068] | conflicting interpretations of pathogenicity|uncertain significance | 11 | 821766 | 821766 | Human | 1 | name |
| 11652488 | CV329603 | single nucleotide variant | NM_020376.4(PNPLA2):c.683C>T (p.Pro228Leu) | Neutral lipid storage myopathy [RCV000305234]|not provided [RCV003480588] | uncertain significance | 11 | 822593 | 822593 | Human | 1 | name |
| 405657989 | CV3376628 | single nucleotide variant | NM_020376.4(PNPLA2):c.400T>C (p.Ser134Pro) | Inborn genetic diseases [RCV004511927] | uncertain significance | 11 | 821840 | 821840 | Human | 1 | name |
| 405657993 | CV3376629 | single nucleotide variant | NM_020376.4(PNPLA2):c.904G>A (p.Ala302Thr) | Inborn genetic diseases [RCV004511928] | uncertain significance | 11 | 823840 | 823840 | Human | 1 | name |
| 407524130 | CV3463844 | single nucleotide variant | NM_020376.4(PNPLA2):c.361G>A (p.Val121Met) | Inborn genetic diseases [RCV004653570] | uncertain significance | 11 | 821801 | 821801 | Human | 1 | name |
| 408381704 | CV3526573 | single nucleotide variant | NM_020376.4(PNPLA2):c.989T>C (p.Leu330Pro) | not provided [RCV004771886] | uncertain significance | 11 | 824067 | 824067 | Human | | name |
| 597692024 | CV3590662 | single nucleotide variant | NM_020376.4(PNPLA2):c.563C>T (p.Ser188Leu) | Inborn genetic diseases [RCV004954289] | uncertain significance | 11 | 822473 | 822473 | Human | 1 | name |
| 597903973 | CV3856282 | single nucleotide variant | NM_020376.4(PNPLA2):c.616C>T (p.Arg206Trp) | Neutral lipid storage myopathy [RCV005202510] | uncertain significance | 11 | 822526 | 822526 | Human | 1 | name |
| 597892823 | CV3856782 | deletion | NM_020376.4(PNPLA2):c.1051del (p.Arg351fs) | Neutral lipid storage myopathy [RCV005200851] | pathogenic|likely pathogenic | 11 | 824128 | 824128 | Human | 1 | name |
| 598187727 | CV4003530 | single nucleotide variant | NM_020376.4(PNPLA2):c.791T>C (p.Leu264Ser) | Inborn genetic diseases [RCV005395964] | uncertain significance | 11 | 823727 | 823727 | Human | 1 | name |
| 598187740 | CV4003532 | single nucleotide variant | NM_020376.4(PNPLA2):c.635T>C (p.Ile212Thr) | Inborn genetic diseases [RCV005395966] | uncertain significance | 11 | 822545 | 822545 | Human | 1 | name |
| 13504174 | CV461485 | single nucleotide variant | NM_020376.4(PNPLA2):c.953T>C (p.Leu318Pro) | Inborn genetic diseases [RCV003278895]|Neutral lipid storage myopathy [RCV000524766] | uncertain significance | 11 | 824031 | 824031 | Human | 2 | name |
| 13485246 | CV461684 | single nucleotide variant | NM_020376.4(PNPLA2):c.425A>G (p.Asn142Ser) | Inborn genetic diseases [RCV002528403]|Neutral lipid storage myopathy [RCV000530684] | uncertain significance | 11 | 821962 | 821962 | Human | 2 | name |
| 13482321 | CV461686 | single nucleotide variant | NM_020376.4(PNPLA2):c.863C>G (p.Ser288Trp) | Neutral lipid storage myopathy [RCV000551812] | benign | 11 | 823799 | 823799 | Human | 1 | name |
| 13493480 | CV461687 | single nucleotide variant | NM_020376.4(PNPLA2):c.907C>G (p.Arg303Gly) | Inborn genetic diseases [RCV003278894]|Neutral lipid storage myopathy [RCV000535714] | uncertain significance | 11 | 823843 | 823843 | Human | 2 | name |
| 13484095 | CV462311 | single nucleotide variant | NM_020376.4(PNPLA2):c.338G>A (p.Arg113His) | Neutral lipid storage myopathy [RCV000552603]|not provided [RCV004691879] | uncertain significance | 11 | 821778 | 821778 | Human | 1 | name |
| 13494396 | CV462316 | single nucleotide variant | NM_020376.4(PNPLA2):c.711G>A (p.Met237Ile) | Neutral lipid storage myopathy [RCV000558880] | uncertain significance | 11 | 823541 | 823541 | Human | 1 | name |
| 13496436 | CV462322 | single nucleotide variant | NM_020376.4(PNPLA2):c.752G>A (p.Arg251Gln) | Inborn genetic diseases [RCV004955639]|Neutral lipid storage myopathy [RCV000537853] | uncertain significance | 11 | 823582 | 823582 | Human | 2 | name |
| 8570685 | CV48465 | single nucleotide variant | NM_020376.4(PNPLA2):c.749A>C (p.Gln250Pro) | Neutral lipid storage myopathy [RCV000033093] | pathogenic | 11 | 823579 | 823579 | Human | 1 | name |
| 13611042 | CV526547 | single nucleotide variant | NM_020376.4(PNPLA2):c.661C>T (p.Arg221Cys) | Neutral lipid storage myopathy [RCV000641663] | uncertain significance | 11 | 822571 | 822571 | Human | 1 | name |
| 13611040 | CV527074 | single nucleotide variant | NM_020376.4(PNPLA2):c.337C>T (p.Arg113Cys) | Neutral lipid storage myopathy [RCV000641662] | uncertain significance | 11 | 821777 | 821777 | Human | 1 | name |
| 13611050 | CV527076 | single nucleotide variant | NM_020376.4(PNPLA2):c.527A>G (p.Tyr176Cys) | Inborn genetic diseases [RCV004025622]|Neutral lipid storage myopathy [RCV000641666] | uncertain significance | 11 | 822437 | 822437 | Human | 2 | name |
| 13806936 | CV564917 | single nucleotide variant | NM_020376.4(PNPLA2):c.844G>A (p.Ala282Thr) | Inborn genetic diseases [RCV004026236]|Neutral lipid storage myopathy [RCV000686438] | uncertain significance | 11 | 823780 | 823780 | Human | 2 | name |
| 13813269 | CV564924 | single nucleotide variant | NM_020376.4(PNPLA2):c.881A>G (p.Asp294Gly) | Neutral lipid storage myopathy [RCV000690037] | uncertain significance | 11 | 823817 | 823817 | Human | 1 | name |
| 13809257 | CV564926 | deletion | NM_020376.4(PNPLA2):c.1043del (p.Phe348fs) | Neutral lipid storage myopathy [RCV000687677] | pathogenic | 11 | 824120 | 824120 | Human | 1 | name |
| 13812092 | CV566203 | single nucleotide variant | NM_020376.4(PNPLA2):c.787G>A (p.Ala263Thr) | Neutral lipid storage myopathy [RCV000703476]|not provided [RCV002259364] | uncertain significance | 11 | 823723 | 823723 | Human | 1 | name |
| 13822046 | CV567560 | single nucleotide variant | NM_020376.4(PNPLA2):c.655C>T (p.Leu219Phe) | Neutral lipid storage myopathy [RCV000696744] | uncertain significance | 11 | 822565 | 822565 | Human | 1 | name |
| 13816326 | CV571023 | single nucleotide variant | NM_020376.4(PNPLA2):c.628A>G (p.Thr210Ala) | Inborn genetic diseases [RCV005392295]|Neutral lipid storage myopathy [RCV000692229] | uncertain significance | 11 | 822538 | 822538 | Human | 2 | name |
| 13817570 | CV571043 | duplication | NM_020376.4(PNPLA2):c.1460dup (p.Leu487fs) | Neutral lipid storage myopathy [RCV000707102] | uncertain significance | 11 | 824805 | 824806 | Human | 1 | name |
| 14732047 | CV640481 | single nucleotide variant | NM_020376.4(PNPLA2):c.401C>G (p.Ser134Cys) | Neutral lipid storage myopathy [RCV000801680] | uncertain significance | 11 | 821841 | 821841 | Human | 1 | name |
| 14745252 | CV640482 | single nucleotide variant | NM_020376.4(PNPLA2):c.448G>A (p.Val150Met) | Inborn genetic diseases [RCV002536029]|Neutral lipid storage myopathy [RCV000824590] | uncertain significance | 11 | 821985 | 821985 | Human | 2 | name |
| 14740437 | CV640483 | single nucleotide variant | NM_020376.4(PNPLA2):c.662G>C (p.Arg221Pro) | Neutral lipid storage myopathy [RCV000821800] | pathogenic | 11 | 822572 | 822572 | Human | 1 | name |
| 14725392 | CV640484 | single nucleotide variant | NM_020376.4(PNPLA2):c.871C>T (p.Pro291Ser) | Inborn genetic diseases [RCV002538005]|Neutral lipid storage myopathy [RCV000798790] | uncertain significance | 11 | 823807 | 823807 | Human | 2 | name |
| 15175529 | CV713218 | single nucleotide variant | NM_020376.4(PNPLA2):c.806C>T (p.Pro269Leu) | Neutral lipid storage myopathy [RCV000972971] | likely benign|conflicting interpretations of pathogenicity | 11 | 823742 | 823742 | Human | 1 | name |
| 26904541 | CV839118 | single nucleotide variant | NM_020376.4(PNPLA2):c.487C>T (p.Arg163Cys) | Inborn genetic diseases [RCV002553238]|Neutral lipid storage myopathy [RCV001050885]|not provided [RCV002265000] | uncertain significance | 11 | 822397 | 822397 | Human | 2 | name |
| 26895372 | CV839120 | single nucleotide variant | NM_020376.4(PNPLA2):c.650G>A (p.Arg217His) | Neutral lipid storage myopathy [RCV001047876] | uncertain significance | 11 | 822560 | 822560 | Human | 1 | name |
| 26887129 | CV839122 | single nucleotide variant | NM_020376.4(PNPLA2):c.779C>T (p.Pro260Leu) | Neutral lipid storage myopathy [RCV001044673] | uncertain significance | 11 | 823715 | 823715 | Human | 1 | name |
| 26923553 | CV839123 | single nucleotide variant | NM_020376.4(PNPLA2):c.803G>A (p.Arg268His) | Inborn genetic diseases [RCV004030527]|Neutral lipid storage myopathy [RCV001064202] | uncertain significance | 11 | 823739 | 823739 | Human | 2 | name |
| 26886835 | CV839124 | single nucleotide variant | NM_020376.4(PNPLA2):c.874G>A (p.Gly292Arg) | Neutral lipid storage myopathy [RCV001066319] | uncertain significance | 11 | 823810 | 823810 | Human | 1 | name |
| 26910383 | CV839125 | single nucleotide variant | NM_020376.4(PNPLA2):c.932C>T (p.Ala311Val) | Neutral lipid storage myopathy [RCV001038632] | uncertain significance | 11 | 824010 | 824010 | Human | 1 | name |
| 26905348 | CV839126 | single nucleotide variant | NM_020376.4(PNPLA2):c.980C>T (p.Pro327Leu) | Neutral lipid storage myopathy [RCV001051249] | uncertain significance | 11 | 824058 | 824058 | Human | 1 | name |
| 26885846 | CV839134 | deletion | NM_020376.4(PNPLA2):c.1353del (p.Asn451fs) | Neutral lipid storage myopathy [RCV001043798] | uncertain significance | 11 | 824700 | 824700 | Human | 1 | name |
| 28911694 | CV868873 | single nucleotide variant | NM_020376.4(PNPLA2):c.407A>G (p.Asp136Gly) | Neutral lipid storage myopathy [RCV001111015] | uncertain significance | 11 | 821847 | 821847 | Human | 1 | name |
| 28869196 | CV868875 | single nucleotide variant | NM_020376.4(PNPLA2):c.649C>T (p.Arg217Cys) | Neutral lipid storage myopathy [RCV001113010] | uncertain significance | 11 | 822559 | 822559 | Human | 1 | name |
| 28911317 | CV868877 | single nucleotide variant | NM_020376.4(PNPLA2):c.962C>T (p.Thr321Ile) | Neutral lipid storage myopathy [RCV001110353] | uncertain significance | 11 | 824040 | 824040 | Human | 1 | name |
| 38463459 | CV919397 | single nucleotide variant | NM_020376.4(PNPLA2):c.731A>G (p.Asp244Gly) | Neutral lipid storage myopathy [RCV001199048] | uncertain significance | 11 | 823561 | 823561 | Human | 1 | name |
| 38487462 | CV926403 | single nucleotide variant | NM_020376.4(PNPLA2):c.617G>A (p.Arg206Gln) | Neutral lipid storage myopathy [RCV001220747] | uncertain significance | 11 | 822527 | 822527 | Human | 1 | name |
| 38488242 | CV926404 | single nucleotide variant | NM_020376.4(PNPLA2):c.772C>T (p.Pro258Ser) | Neutral lipid storage myopathy [RCV001221124] | uncertain significance | 11 | 823708 | 823708 | Human | 1 | name |
| 38477986 | CV935835 | single nucleotide variant | NM_020376.4(PNPLA2):c.353T>C (p.Leu118Pro) | Neutral lipid storage myopathy [RCV001205344] | uncertain significance | 11 | 821793 | 821793 | Human | 1 | name |
| 38497785 | CV947721 | single nucleotide variant | NM_020376.4(PNPLA2):c.373G>A (p.Glu125Lys) | Neutral lipid storage myopathy [RCV001227314]|not provided [RCV003334038] | uncertain significance | 11 | 821813 | 821813 | Human | 1 | name |
| 38485284 | CV947722 | single nucleotide variant | NM_020376.4(PNPLA2):c.787G>T (p.Ala263Ser) | Neutral lipid storage myopathy [RCV001236693] | uncertain significance | 11 | 823723 | 823723 | Human | 1 | name |
| 38494546 | CV956705 | single nucleotide variant | NM_020376.4(PNPLA2):c.756C>A (p.Asn252Lys) | Neutral lipid storage myopathy [RCV001241375] | likely benign|uncertain significance | 11 | 823586 | 823586 | Human | 1 | name |
| 39456876 | CV965654 | single nucleotide variant | NM_020376.4(PNPLA2):c.553T>C (p.Ser185Pro) | Neutral lipid storage myopathy [RCV001255206] | uncertain significance | 11 | 822463 | 822463 | Human | 1 | name |
| 126748930 | CV1030577 | single nucleotide variant | NM_020376.4(PNPLA2):c.1002G>A (p.Met334Ile) | Neutral lipid storage myopathy [RCV001337751] | uncertain significance | 11 | 824080 | 824080 | Human | 1 | name |
| 126763965 | CV1030579 | single nucleotide variant | NM_020376.4(PNPLA2):c.1316G>A (p.Cys439Tyr) | Inborn genetic diseases [RCV003355407]|Neutral lipid storage myopathy [RCV001341479] | uncertain significance | 11 | 824663 | 824663 | Human | 2 | name |
| 126908166 | CV1047581 | single nucleotide variant | NM_020376.4(PNPLA2):c.1021C>T (p.Pro341Ser) | Neutral lipid storage myopathy [RCV001367661] | uncertain significance | 11 | 824099 | 824099 | Human | 1 | name |
| 126911047 | CV1047582 | single nucleotide variant | NM_020376.4(PNPLA2):c.1201C>T (p.Arg401Cys) | Neutral lipid storage myopathy [RCV001369041] | uncertain significance | 11 | 824548 | 824548 | Human | 1 | name |
| 151236047 | CV1319478 | single nucleotide variant | NM_020376.4(PNPLA2):c.1513T>A (p.Ter505Arg) | not provided [RCV001797423] | uncertain significance | 11 | 824860 | 824860 | Human | | name |
| 151785161 | CV1342631 | single nucleotide variant | NM_020376.4(PNPLA2):c.1478C>T (p.Pro493Leu) | Neutral lipid storage myopathy [RCV002010108] | uncertain significance | 11 | 824825 | 824825 | Human | 1 | name |
| 151849745 | CV1355166 | single nucleotide variant | NM_020376.4(PNPLA2):c.1353C>A (p.Asn451Lys) | Neutral lipid storage myopathy [RCV001957815] | uncertain significance | 11 | 824700 | 824700 | Human | 1 | name |
| 151782060 | CV1360448 | single nucleotide variant | NM_020376.4(PNPLA2):c.1363C>T (p.Pro455Ser) | Neutral lipid storage myopathy [RCV001865057] | uncertain significance | 11 | 824710 | 824710 | Human | 1 | name |
| 151877436 | CV1368851 | single nucleotide variant | NM_020376.4(PNPLA2):c.1508G>C (p.Gly503Ala) | Neutral lipid storage myopathy [RCV001999107] | uncertain significance | 11 | 824855 | 824855 | Human | 1 | name |
| 151819370 | CV1385850 | single nucleotide variant | NM_020376.4(PNPLA2):c.1222G>T (p.Val408Leu) | Neutral lipid storage myopathy [RCV002013220] | uncertain significance | 11 | 824569 | 824569 | Human | 1 | name |
| 151846477 | CV1386536 | single nucleotide variant | NM_020376.4(PNPLA2):c.1251G>C (p.Glu417Asp) | Neutral lipid storage myopathy [RCV001882009] | uncertain significance | 11 | 824598 | 824598 | Human | 1 | name |
| 151860112 | CV1400035 | single nucleotide variant | NM_020376.4(PNPLA2):c.1145A>G (p.Lys382Arg) | Neutral lipid storage myopathy [RCV001997031] | uncertain significance | 11 | 824406 | 824406 | Human | 1 | name |
| 151738583 | CV1432653 | single nucleotide variant | NM_020376.4(PNPLA2):c.1480G>A (p.Glu494Lys) | Neutral lipid storage myopathy [RCV002022094] | uncertain significance | 11 | 824827 | 824827 | Human | 1 | name |
| 151744483 | CV1432861 | single nucleotide variant | NM_020376.4(PNPLA2):c.1399C>T (p.Pro467Ser) | Neutral lipid storage myopathy [RCV001968486] | uncertain significance | 11 | 824746 | 824746 | Human | 1 | name |
| 151807408 | CV1450102 | single nucleotide variant | NM_020376.4(PNPLA2):c.1210T>G (p.Ser404Ala) | Neutral lipid storage myopathy [RCV001899623] | uncertain significance | 11 | 824557 | 824557 | Human | 1 | name |
| 151847438 | CV1461783 | single nucleotide variant | NM_020376.4(PNPLA2):c.1138C>G (p.Arg380Gly) | Neutral lipid storage myopathy [RCV001936899] | uncertain significance | 11 | 824399 | 824399 | Human | 1 | name |
| 151727699 | CV1486383 | single nucleotide variant | NM_020376.4(PNPLA2):c.1427C>A (p.Ser476Tyr) | Neutral lipid storage myopathy [RCV001891923] | uncertain significance | 11 | 824774 | 824774 | Human | 1 | name |
| 151812969 | CV1498255 | single nucleotide variant | NM_020376.4(PNPLA2):c.1204G>C (p.Val402Leu) | Neutral lipid storage myopathy [RCV001954009] | uncertain significance | 11 | 824551 | 824551 | Human | 1 | name |
| 151735787 | CV1508899 | single nucleotide variant | NM_020376.4(PNPLA2):c.1457C>A (p.Pro486His) | Inborn genetic diseases [RCV003161273]|Neutral lipid storage myopathy [RCV002021795] | uncertain significance | 11 | 824804 | 824804 | Human | 2 | name |
| 151819168 | CV1513944 | single nucleotide variant | NM_020376.4(PNPLA2):c.1375C>G (p.Leu459Val) | Neutral lipid storage myopathy [RCV001933972] | uncertain significance | 11 | 824722 | 824722 | Human | 1 | name |
| 152091112 | CV1654970 | indel | NM_020376.4(PNPLA2):c.696+15_696+16delinsAG | Neutral lipid storage myopathy [RCV002212738] | likely benign | 11 | 822621 | 822622 | Human | | name |
| 155644064 | CV1708386 | single nucleotide variant | NM_020376.4(PNPLA2):c.1204G>A (p.Val402Ile) | Neutral lipid storage myopathy [RCV002290375] | uncertain significance | 11 | 824551 | 824551 | Human | 1 | name |
| 156405391 | CV1893805 | single nucleotide variant | NM_020376.4(PNPLA2):c.1112G>C (p.Gly371Ala) | Neutral lipid storage myopathy [RCV003070008] | uncertain significance | 11 | 824373 | 824373 | Human | 1 | name |
| 156302124 | CV1916161 | single nucleotide variant | NM_020376.4(PNPLA2):c.1457C>G (p.Pro486Arg) | Neutral lipid storage myopathy [RCV002599223] | uncertain significance | 11 | 824804 | 824804 | Human | 1 | name |
| 155962747 | CV1931690 | single nucleotide variant | NM_020376.4(PNPLA2):c.1283C>T (p.Ser428Leu) | Neutral lipid storage myopathy [RCV002616813] | uncertain significance | 11 | 824630 | 824630 | Human | 1 | name |
| 156209952 | CV1932435 | single nucleotide variant | NM_020376.4(PNPLA2):c.1181C>T (p.Pro394Leu) | Neutral lipid storage myopathy [RCV002643956] | uncertain significance | 11 | 824528 | 824528 | Human | 1 | name |
| 156412729 | CV1968795 | single nucleotide variant | NM_020376.4(PNPLA2):c.1232C>T (p.Ser411Phe) | Neutral lipid storage myopathy [RCV002608624] | uncertain significance | 11 | 824579 | 824579 | Human | 1 | name |
| 156154721 | CV1991482 | single nucleotide variant | NM_020376.4(PNPLA2):c.1337G>A (p.Gly446Asp) | Neutral lipid storage myopathy [RCV002642192] | uncertain significance | 11 | 824684 | 824684 | Human | 1 | name |
| 156095096 | CV2010534 | single nucleotide variant | NM_020376.4(PNPLA2):c.1107G>C (p.Gln369His) | Neutral lipid storage myopathy [RCV002695086] | uncertain significance | 11 | 824368 | 824368 | Human | 1 | name |
| 156092757 | CV2012612 | single nucleotide variant | NM_020376.4(PNPLA2):c.1132G>C (p.Val378Leu) | Neutral lipid storage myopathy [RCV002706373] | uncertain significance | 11 | 824393 | 824393 | Human | 1 | name |
| 156192517 | CV2017836 | single nucleotide variant | NM_020376.4(PNPLA2):c.1354G>A (p.Val452Met) | Neutral lipid storage myopathy [RCV002700006] | uncertain significance | 11 | 824701 | 824701 | Human | 1 | name |
| 156251161 | CV2041063 | single nucleotide variant | NM_020376.4(PNPLA2):c.1168C>T (p.Pro390Ser) | Neutral lipid storage myopathy [RCV002806014] | uncertain significance | 11 | 824429 | 824429 | Human | 1 | name |
| 156208688 | CV2042430 | single nucleotide variant | NM_020376.4(PNPLA2):c.1336G>C (p.Gly446Arg) | Inborn genetic diseases [RCV004958753]|Neutral lipid storage myopathy [RCV002766514] | uncertain significance | 11 | 824683 | 824683 | Human | 2 | name |
| 156035183 | CV2047533 | single nucleotide variant | NM_020376.4(PNPLA2):c.1376T>C (p.Leu459Pro) | Neutral lipid storage myopathy [RCV002781275] | uncertain significance | 11 | 824723 | 824723 | Human | 1 | name |
| 155966467 | CV2048436 | single nucleotide variant | NM_020376.4(PNPLA2):c.1421C>T (p.Pro474Leu) | Neutral lipid storage myopathy [RCV002776515] | uncertain significance | 11 | 824768 | 824768 | Human | 1 | name |
| 156326056 | CV2108571 | single nucleotide variant | NM_020376.4(PNPLA2):c.1211C>T (p.Ser404Leu) | Neutral lipid storage myopathy [RCV002938089] | uncertain significance | 11 | 824558 | 824558 | Human | 1 | name |
| 156355114 | CV2129829 | single nucleotide variant | NM_020376.4(PNPLA2):c.1346G>C (p.Cys449Ser) | Neutral lipid storage myopathy [RCV002966596] | uncertain significance | 11 | 824693 | 824693 | Human | 1 | name |
| 155977658 | CV2132518 | single nucleotide variant | NM_020376.4(PNPLA2):c.1468A>G (p.Thr490Ala) | Neutral lipid storage myopathy [RCV002995936] | uncertain significance | 11 | 824815 | 824815 | Human | 1 | name |
| 156261349 | CV2143260 | single nucleotide variant | NM_020376.4(PNPLA2):c.1226C>A (p.Pro409Gln) | Neutral lipid storage myopathy [RCV003008935] | uncertain significance | 11 | 824573 | 824573 | Human | 1 | name |
| 155999687 | CV2149247 | single nucleotide variant | NM_020376.4(PNPLA2):c.1351A>G (p.Asn451Asp) | Neutral lipid storage myopathy [RCV002996957] | uncertain significance | 11 | 824698 | 824698 | Human | 1 | name |
| 156053477 | CV2242971 | single nucleotide variant | NM_020376.4(PNPLA2):c.1150A>C (p.Lys384Gln) | Inborn genetic diseases [RCV002782160] | uncertain significance | 11 | 824411 | 824411 | Human | 1 | name |
| 156155207 | CV2374992 | single nucleotide variant | NM_020376.4(PNPLA2):c.1439A>G (p.Gln480Arg) | Inborn genetic diseases [RCV002709906] | uncertain significance | 11 | 824786 | 824786 | Human | 1 | name |
| 243059592 | CV2413424 | single nucleotide variant | NM_020376.4(PNPLA2):c.1459T>G (p.Leu487Val) | Neutral lipid storage myopathy [RCV003135058] | uncertain significance | 11 | 824806 | 824806 | Human | 1 | name |
| 243059595 | CV2413427 | single nucleotide variant | NM_020376.4(PNPLA2):c.1142C>T (p.Ala381Val) | Neutral lipid storage myopathy [RCV003135061] | uncertain significance | 11 | 824403 | 824403 | Human | 1 | name |
| 243050540 | CV2413430 | single nucleotide variant | NM_020376.4(PNPLA2):c.1454C>T (p.Ala485Val) | Neutral lipid storage myopathy [RCV003130281] | uncertain significance | 11 | 824801 | 824801 | Human | 1 | name |
| 243059600 | CV2413435 | single nucleotide variant | NM_020376.4(PNPLA2):c.1421C>G (p.Pro474Arg) | Inborn genetic diseases [RCV004246044]|Neutral lipid storage myopathy [RCV003135067] | uncertain significance | 11 | 824768 | 824768 | Human | 2 | name |
| 11546051 | CV254353 | single nucleotide variant | NM_020376.4(PNPLA2):c.1327C>G (p.Leu443Val) | Inborn genetic diseases [RCV002518646]|Neutral lipid storage myopathy [RCV000343309]|not specified [RCV000245958] | likely benign|conflicting interpretations of pathogenicity|uncertain significance | 11 | 824674 | 824674 | Human | 2 | name |
| 11549505 | CV254354 | single nucleotide variant | NM_020376.4(PNPLA2):c.1364C>A (p.Pro455Gln) | Inborn genetic diseases [RCV002518647]|Neutral lipid storage myopathy [RCV000401957]|not specified [RCV000250507] | likely benign|conflicting interpretations of pathogenicity|uncertain significance | 11 | 824711 | 824711 | Human | 2 | name |
| 11543458 | CV254355 | single nucleotide variant | NM_020376.4(PNPLA2):c.1430C>G (p.Pro477Arg) | Neutral lipid storage myopathy [RCV000284101]|not provided [RCV001706356]|not specified [RCV000242486] | benign|likely benign|conflicting interpretations of pathogenicity | 11 | 824777 | 824777 | Human | 1 | name |
| 11545710 | CV254356 | single nucleotide variant | NM_020376.4(PNPLA2):c.1430C>T (p.Pro477Leu) | Neutral lipid storage myopathy [RCV001084354]|not provided [RCV000714556]|not specified [RCV000245505] | benign|likely benign|conflicting interpretations of pathogenicity | 11 | 824777 | 824777 | Human | 1 | name |
| 11549459 | CV254357 | single nucleotide variant | NM_020376.4(PNPLA2):c.1442T>C (p.Leu481Pro) | Neutral lipid storage myopathy [RCV000336767]|not provided [RCV001610715]|not specified [RCV000250452] | benign | 11 | 824789 | 824789 | Human | 1 | name |
| 401887271 | CV2773282 | single nucleotide variant | NM_020376.4(PNPLA2):c.1258C>T (p.Pro420Ser) | Inborn genetic diseases [RCV003367098] | uncertain significance | 11 | 824605 | 824605 | Human | 1 | name |
| 404977586 | CV2850833 | single nucleotide variant | NM_020376.4(PNPLA2):c.1435C>A (p.His479Asn) | Neutral lipid storage myopathy [RCV003486204] | uncertain significance | 11 | 824782 | 824782 | Human | 1 | name |
| 404977588 | CV2850834 | single nucleotide variant | NM_020376.4(PNPLA2):c.1450C>A (p.Pro484Thr) | Neutral lipid storage myopathy [RCV003486205] | uncertain significance | 11 | 824797 | 824797 | Human | 1 | name |
| 402470529 | CV3175200 | single nucleotide variant | NM_020376.4(PNPLA2):c.1198C>T (p.Arg400Cys) | Neutral lipid storage myopathy [RCV003874132] | uncertain significance | 11 | 824545 | 824545 | Human | 1 | name |
| 11610539 | CV322210 | single nucleotide variant | NM_020376.4(PNPLA2):c.1181C>A (p.Pro394Gln) | Inborn genetic diseases [RCV002520774]|Neutral lipid storage myopathy [RCV000382845] | conflicting interpretations of pathogenicity|uncertain significance | 11 | 824528 | 824528 | Human | 2 | name |
| 11615482 | CV328300 | single nucleotide variant | NM_020376.4(PNPLA2):c.1220C>T (p.Ser407Phe) | Neutral lipid storage myopathy [RCV000286119]|not provided [RCV003221903] | likely benign|conflicting interpretations of pathogenicity|uncertain significance | 11 | 824567 | 824567 | Human | 1 | name |
| 11616689 | CV329608 | single nucleotide variant | NM_020376.4(PNPLA2):c.1466G>T (p.Ser489Ile) | Neutral lipid storage myopathy [RCV000297114]|not provided [RCV003221904] | benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance | 11 | 824813 | 824813 | Human | 1 | name |
| 405657983 | CV3376626 | single nucleotide variant | NM_020376.4(PNPLA2):c.1244A>G (p.Tyr415Cys) | Inborn genetic diseases [RCV004511925] | uncertain significance | 11 | 824591 | 824591 | Human | 1 | name |
| 405657986 | CV3376627 | single nucleotide variant | NM_020376.4(PNPLA2):c.1358C>T (p.Ala453Val) | Inborn genetic diseases [RCV004511926] | uncertain significance | 11 | 824705 | 824705 | Human | 1 | name |
| 597692038 | CV3590664 | single nucleotide variant | NM_020376.4(PNPLA2):c.1481A>T (p.Glu494Val) | Inborn genetic diseases [RCV004954291] | uncertain significance | 11 | 824828 | 824828 | Human | 1 | name |
| 597946535 | CV3755604 | single nucleotide variant | NM_020376.4(PNPLA2):c.1105C>T (p.Gln369Ter) | Neutral lipid storage myopathy [RCV005078614] | pathogenic | 11 | 824366 | 824366 | Human | 1 | name |
| 598187724 | CV4003529 | single nucleotide variant | NM_020376.4(PNPLA2):c.1396G>C (p.Asp466His) | Inborn genetic diseases [RCV005395963] | uncertain significance | 11 | 824743 | 824743 | Human | 1 | name |
| 13211570 | CV425945 | single nucleotide variant | NM_020376.4(PNPLA2):c.1277A>G (p.Asn426Ser) | Neutral lipid storage myopathy [RCV001079255]|PNPLA2-related disorder [RCV004755935]|not provided [RCV000497628] | likely benign|conflicting interpretations of pathogenicity|uncertain significance | 11 | 824624 | 824624 | Human | 2 | name , trait , alternate_id |
| 13466056 | CV462019 | single nucleotide variant | NM_020376.4(PNPLA2):c.1415C>G (p.Ala472Gly) | Inborn genetic diseases [RCV004649194]|Neutral lipid storage myopathy [RCV000543186] | uncertain significance | 11 | 824762 | 824762 | Human | 2 | name |
| 13500493 | CV462327 | single nucleotide variant | NM_020376.4(PNPLA2):c.1237G>A (p.Ala413Thr) | Neutral lipid storage myopathy [RCV000540444] | benign | 11 | 824584 | 824584 | Human | 1 | name |
| 13494519 | CV462328 | single nucleotide variant | NM_020376.4(PNPLA2):c.1447G>C (p.Gly483Arg) | Neutral lipid storage myopathy [RCV000536455] | uncertain significance | 11 | 824794 | 824794 | Human | 1 | name |
| 13491143 | CV462331 | single nucleotide variant | NM_020376.4(PNPLA2):c.1486C>T (p.Arg496Trp) | Neutral lipid storage myopathy [RCV000556497]|PNPLA2-related disorder [RCV004755959] | uncertain significance | 11 | 824833 | 824833 | Human | 2 | name , trait , alternate_id |
| 13611053 | CV526491 | single nucleotide variant | NM_020376.4(PNPLA2):c.1339C>T (p.Leu447Phe) | Inborn genetic diseases [RCV003243227]|Neutral lipid storage myopathy [RCV000641667] | uncertain significance | 11 | 824686 | 824686 | Human | 2 | name |
| 13611045 | CV526498 | single nucleotide variant | NM_020376.4(PNPLA2):c.1456C>T (p.Pro486Ser) | Neutral lipid storage myopathy [RCV000641664] | uncertain significance | 11 | 824803 | 824803 | Human | 1 | name |
| 13611033 | CV526555 | single nucleotide variant | NM_020376.4(PNPLA2):c.1150A>G (p.Lys384Glu) | Neutral lipid storage myopathy [RCV000641659] | uncertain significance | 11 | 824411 | 824411 | Human | 1 | name |
| 13611048 | CV526558 | single nucleotide variant | NM_020376.4(PNPLA2):c.1406C>T (p.Pro469Leu) | Inborn genetic diseases [RCV003278965]|Neutral lipid storage myopathy [RCV000641665]|not provided [RCV004723020] | uncertain significance | 11 | 824753 | 824753 | Human | 2 | name |
| 13611036 | CV526796 | single nucleotide variant | NM_020376.4(PNPLA2):c.1111G>A (p.Gly371Ser) | Neutral lipid storage myopathy [RCV000641660] | uncertain significance | 11 | 824372 | 824372 | Human | 1 | name |
| 13804882 | CV566205 | single nucleotide variant | NM_020376.4(PNPLA2):c.1102G>C (p.Glu368Gln) | Neutral lipid storage myopathy [RCV000685439] | uncertain significance | 11 | 824363 | 824363 | Human | 1 | name |
| 13820510 | CV566207 | single nucleotide variant | NM_020376.4(PNPLA2):c.1433A>G (p.Gln478Arg) | Neutral lipid storage myopathy [RCV000694920] | uncertain significance | 11 | 824780 | 824780 | Human | 1 | name |
| 13811178 | CV571037 | single nucleotide variant | NM_020376.4(PNPLA2):c.1408G>A (p.Ala470Thr) | Inborn genetic diseases [RCV002533673]|Neutral lipid storage myopathy [RCV000702958]|not provided [RCV003227837] | uncertain significance | 11 | 824755 | 824755 | Human | 2 | name |
| 14693485 | CV620423 | single nucleotide variant | NM_020376.4(PNPLA2):c.1266G>A (p.Trp422Ter) | Neutral lipid storage myopathy [RCV000779083]|PNPLA2-related disorder [RCV004756032]|not provided [RCV002254316] | likely pathogenic|uncertain significance | 11 | 824613 | 824613 | Human | 2 | name , trait , alternate_id |
| 14705665 | CV640485 | single nucleotide variant | NM_020376.4(PNPLA2):c.1139G>A (p.Arg380His) | Inborn genetic diseases [RCV002535849]|Neutral lipid storage myopathy [RCV000791759] | uncertain significance | 11 | 824400 | 824400 | Human | 2 | name |
| 14727406 | CV640486 | single nucleotide variant | NM_020376.4(PNPLA2):c.1279C>T (p.Leu427Phe) | Neutral lipid storage myopathy [RCV000799634] | uncertain significance | 11 | 824626 | 824626 | Human | 1 | name |
| 14719392 | CV640488 | single nucleotide variant | NM_020376.4(PNPLA2):c.1484C>A (p.Ala495Asp) | Inborn genetic diseases [RCV005392401]|Neutral lipid storage myopathy [RCV000796184]|not provided [RCV001091844] | uncertain significance | 11 | 824831 | 824831 | Human | 2 | name |
| 15128747 | CV693119 | single nucleotide variant | NM_020376.4(PNPLA2):c.1483G>A (p.Ala495Thr) | Neutral lipid storage myopathy [RCV000875538] | likely benign | 11 | 824830 | 824830 | Human | 1 | name |
| 15164089 | CV713219 | single nucleotide variant | NM_020376.4(PNPLA2):c.1090C>T (p.Arg364Trp) | Neutral lipid storage myopathy [RCV001111096]|not provided [RCV003328640] | likely benign|conflicting interpretations of pathogenicity|uncertain significance | 11 | 824351 | 824351 | Human | 1 | name |
| 26892002 | CV839127 | single nucleotide variant | NM_020376.4(PNPLA2):c.1051C>A (p.Arg351Ser) | Neutral lipid storage myopathy [RCV001068494] | uncertain significance | 11 | 824129 | 824129 | Human | 1 | name |
| 26901759 | CV839128 | single nucleotide variant | NM_020376.4(PNPLA2):c.1061A>G (p.Glu354Gly) | Neutral lipid storage myopathy [RCV001050000] | uncertain significance | 11 | 824322 | 824322 | Human | 1 | name |
| 26904604 | CV839129 | single nucleotide variant | NM_020376.4(PNPLA2):c.1072G>A (p.Asp358Asn) | Neutral lipid storage myopathy [RCV001036633] | uncertain significance | 11 | 824333 | 824333 | Human | 1 | name |
| 26887166 | CV839130 | single nucleotide variant | NM_020376.4(PNPLA2):c.1138C>T (p.Arg380Cys) | Neutral lipid storage myopathy [RCV001044704] | uncertain significance | 11 | 824399 | 824399 | Human | 1 | name |
| 26918841 | CV839131 | single nucleotide variant | NM_020376.4(PNPLA2):c.1217C>T (p.Pro406Leu) | Inborn genetic diseases [RCV003283925]|Neutral lipid storage myopathy [RCV001058327]|not provided [RCV004797895] | uncertain significance | 11 | 824564 | 824564 | Human | 2 | name |
| 26922561 | CV839132 | single nucleotide variant | NM_020376.4(PNPLA2):c.1226C>T (p.Pro409Leu) | Neutral lipid storage myopathy [RCV001062318] | uncertain significance | 11 | 824573 | 824573 | Human | 1 | name |
| 26922268 | CV839133 | single nucleotide variant | NM_020376.4(PNPLA2):c.1328T>G (p.Leu443Arg) | Neutral lipid storage myopathy [RCV001061772] | uncertain significance | 11 | 824675 | 824675 | Human | 1 | name |
| 26907630 | CV839135 | single nucleotide variant | NM_020376.4(PNPLA2):c.1411C>T (p.Pro471Ser) | Neutral lipid storage myopathy [RCV001038053] | uncertain significance | 11 | 824758 | 824758 | Human | 1 | name |
| 26913898 | CV839136 | single nucleotide variant | NM_020376.4(PNPLA2):c.1429C>G (p.Pro477Ala) | Neutral lipid storage myopathy [RCV001054564] | uncertain significance | 11 | 824776 | 824776 | Human | 1 | name |
| 28869378 | CV868878 | single nucleotide variant | NM_020376.4(PNPLA2):c.1349C>T (p.Thr450Ile) | Neutral lipid storage myopathy [RCV001113090] | uncertain significance | 11 | 824696 | 824696 | Human | 1 | name |
| 38478453 | CV926406 | single nucleotide variant | NM_020376.4(PNPLA2):c.1336G>A (p.Gly446Ser) | Neutral lipid storage myopathy [RCV001216603] | uncertain significance | 11 | 824683 | 824683 | Human | 1 | name |
| 38476866 | CV926407 | single nucleotide variant | NM_020376.4(PNPLA2):c.1364C>T (p.Pro455Leu) | Neutral lipid storage myopathy [RCV001215859] | uncertain significance | 11 | 824711 | 824711 | Human | 1 | name |
| 38478756 | CV926408 | single nucleotide variant | NM_020376.4(PNPLA2):c.1409C>T (p.Ala470Val) | Neutral lipid storage myopathy [RCV001216753] | uncertain significance | 11 | 824756 | 824756 | Human | 1 | name |
| 38477600 | CV935836 | single nucleotide variant | NM_020376.4(PNPLA2):c.1154T>C (p.Leu385Pro) | Neutral lipid storage myopathy [RCV001205161] | uncertain significance | 11 | 824415 | 824415 | Human | 1 | name |
| 38478547 | CV935837 | single nucleotide variant | NM_020376.4(PNPLA2):c.1226C>G (p.Pro409Arg) | Inborn genetic diseases [RCV004960533]|Neutral lipid storage myopathy [RCV001205599] | uncertain significance | 11 | 824573 | 824573 | Human | 2 | name |
| 38468819 | CV935838 | single nucleotide variant | NM_020376.4(PNPLA2):c.1240G>A (p.Ala414Thr) | Inborn genetic diseases [RCV004659380]|Neutral lipid storage myopathy [RCV001202251] | likely benign|uncertain significance | 11 | 824587 | 824587 | Human | 2 | name |
| 38481056 | CV935839 | single nucleotide variant | NM_020376.4(PNPLA2):c.1396G>A (p.Asp466Asn) | Neutral lipid storage myopathy [RCV001206668] | uncertain significance | 11 | 824743 | 824743 | Human | 1 | name |
| 38466931 | CV935840 | single nucleotide variant | NM_020376.4(PNPLA2):c.1447G>A (p.Gly483Arg) | Neutral lipid storage myopathy [RCV001201931] | uncertain significance | 11 | 824794 | 824794 | Human | 1 | name |
| 38459972 | CV947723 | single nucleotide variant | NM_020376.4(PNPLA2):c.1379G>T (p.Arg460Leu) | Neutral lipid storage myopathy [RCV001229251] | uncertain significance | 11 | 824726 | 824726 | Human | 1 | name |
| 38458065 | CV956706 | single nucleotide variant | NM_020376.4(PNPLA2):c.1010C>T (p.Pro337Leu) | Neutral lipid storage myopathy [RCV001246220] | uncertain significance | 11 | 824088 | 824088 | Human | 1 | name |
| 38490540 | CV956707 | single nucleotide variant | NM_020376.4(PNPLA2):c.1253C>T (p.Ala418Val) | Neutral lipid storage myopathy [RCV001238886] | uncertain significance | 11 | 824600 | 824600 | Human | 1 | name |
| 126764254 | CV994829 | single nucleotide variant | NM_020376.4(PNPLA2):c.1266G>C (p.Trp422Cys) | Neutral lipid storage myopathy [RCV001301018] | uncertain significance | 11 | 824613 | 824613 | Human | 1 | name |
| 126759073 | CV994830 | single nucleotide variant | NM_020376.4(PNPLA2):c.1414G>A (p.Ala472Thr) | Neutral lipid storage myopathy [RCV001299386] | uncertain significance | 11 | 824761 | 824761 | Human | 1 | name |
| 126752709 | CV994831 | single nucleotide variant | NM_020376.4(PNPLA2):c.1484C>T (p.Ala495Val) | Neutral lipid storage myopathy [RCV001307271] | uncertain significance | 11 | 824831 | 824831 | Human | 1 | name |
| 126733434 | CV994832 | single nucleotide variant | NM_020376.4(PNPLA2):c.1486C>G (p.Arg496Gly) | Neutral lipid storage myopathy [RCV001294738] | uncertain significance | 11 | 824833 | 824833 | Human | 1 | name |
| 151807676 | CV1477670 | deletion | NM_020376.4(PNPLA2):c.856_877del (p.Asp286fs) | Neutral lipid storage myopathy [RCV001953511] | pathogenic | 11 | 823787 | 823808 | Human | 1 | name |
| 13817535 | CV571035 | deletion | NM_020376.4(PNPLA2):c.926_936del (p.Leu309fs) | Neutral lipid storage myopathy [RCV000707081] | uncertain significance | 11 | 823999 | 824009 | Human | 1 | name |
| 8573218 | CV76351 | microsatellite | NM_020376.4(PNPLA2):c.475_478dup (p.Gln160fs) | Neutral lipid storage myopathy [RCV000055643] | pathogenic | 11 | 822000 | 822001 | Human | | name |
| 151876666 | CV1490210 | deletion | NM_020376.4(PNPLA2):c.537_539del (p.Lys179del) | Neutral lipid storage myopathy [RCV001940476] | uncertain significance | 11 | 822445 | 822447 | Human | 1 | name |
| 243050535 | CV2413423 | deletion | NM_020376.4(PNPLA2):c.1447_1451del (p.Gly483fs) | Neutral lipid storage myopathy [RCV003130280] | uncertain significance | 11 | 824790 | 824794 | Human | 1 | name |
| 596932557 | CV3539179 | duplication | NM_020376.4(PNPLA2):c.1416_1432dup (p.Gln478fs) | not provided [RCV004793305] | uncertain significance | 11 | 824756 | 824757 | Human | | name |
| 596932558 | CV3539180 | microsatellite | NM_020376.4(PNPLA2):c.1488_1492dup (p.Val498fs) | not provided [RCV004793306] | uncertain significance | 11 | 824828 | 824829 | Human | | name |
| 151765789 | CV1387592 | duplication | NM_020376.4(PNPLA2):c.1376_1378dup (p.Leu459dup) | Neutral lipid storage myopathy [RCV001987761] | uncertain significance | 11 | 824721 | 824722 | Human | 1 | name |
| 156286335 | CV2134166 | deletion | NM_020376.4(PNPLA2):c.1042_1044del (p.Phe348del) | Neutral lipid storage myopathy [RCV003009784] | uncertain significance | 11 | 824119 | 824121 | Human | 1 | name |
| 13504330 | CV461477 | indel | NM_020376.4(PNPLA2):c.310_311delinsAT (p.Ala104Ile) | Neutral lipid storage myopathy [RCV000527379] | uncertain significance | 11 | 821750 | 821751 | Human | | name |
| 38491176 | CV956704 | indel | NM_020376.4(PNPLA2):c.738_739delinsAA (p.Arg247Ser) | Neutral lipid storage myopathy [RCV001239292] | uncertain significance | 11 | 823568 | 823569 | Human | | name |
| 127233631 | CV1062538 | deletion | NM_020376.4(PNPLA2):c.999del (p.Ala333_Met334insTer) | Neutral lipid storage myopathy [RCV001383465] | pathogenic | 11 | 824076 | 824076 | Human | 1 | name |
| 127286039 | CV1161631 | deletion | NM_020376.4(PNPLA2):c.399_404del (p.Asn133_Ser134del) | Neutral lipid storage myopathy [RCV001526397] | uncertain significance | 11 | 821836 | 821841 | Human | 1 | name |
| 156408354 | CV1869979 | deletion | NM_020376.4(PNPLA2):c.902_910del (p.Pro301_Arg303del) | Neutral lipid storage myopathy [RCV003071234] | uncertain significance | 11 | 823836 | 823844 | Human | 1 | name |
| 13488356 | CV462016 | indel | NM_020376.4(PNPLA2):c.1243_1245delinsCAG (p.Tyr415Gln) | Neutral lipid storage myopathy [RCV000554760] | uncertain significance | 11 | 824590 | 824592 | Human | | name |
| 404977590 | CV2850835 | deletion | NM_020376.4(PNPLA2):c.1416_1475del (p.Asp473_Ala492del) | Neutral lipid storage myopathy [RCV003486206] | uncertain significance | 11 | 824761 | 824820 | Human | 1 | name |
| 13492452 | CV461689 | deletion | NM_020376.4(PNPLA2):c.1487_1504del (p.Arg496_Ala501del) | Neutral lipid storage myopathy [RCV000534968]|See cases [RCV002252161] | uncertain significance | 11 | 824829 | 824846 | Human | 1 | name |
| 11543104 | CV254359 | indel | NM_020376.4(PNPLA2):c.1458_1459delinsTC (p.Pro486_Leu487=) | Neutral lipid storage myopathy [RCV001461226]|not specified [RCV000242016] | likely benign | 11 | 824805 | 824806 | Human | | name |
| 156025241 | CV2043440 | duplication | NM_020376.4(PNPLA2):c.1401_1421dup (p.Ala475_Ser476insProAlaProAlaAspProAla) | Neutral lipid storage myopathy [RCV002780861] | uncertain significance | 11 | 824742 | 824743 | Human | 1 | name |
| 405114892 | CV2901420 | insertion | NM_020376.4(PNPLA2):c.231_232insGGGTGGAGACGGGGTTTCGCTGTGTTGGCCGGGCTGGTCTCCAGCTCCTAACCGCGAGTGATCCGCCAGCCTCGNNNNNNNNNNAAAAAAAAAAAAAAAAAAAAAAAGAGGCCCGG (p.Lys78delinsGlyTrpArgArgGlyPheAlaValLeuAlaGlyLeuValSerSerSerTer) | Neutral lipid storage myopathy [RCV003499962] | pathogenic | 11 | 821659 | 821660 | Human | 1 | name |